











Title of Document: YEAST PSEUDO-HAPLOINSUFFICIENCY 
AS A MODEL SYSTEM FOR HUMAN 
RIBOSOMOPATHIES   
  
 Ryan C. Kobylarz, Doctor of Philosophy, 
2015 
  
Directed By: Dr. Jonathan D. Dinman, Department of 
Cell Biology and Molecular Genetics 
 
 
Ribosomopathies belong to a class of human diseases caused by 
mutations in genes that encode ribosomal proteins, ribosomal biogenesis 
factors, ribosomal RNA (rRNA) or rRNA post-transcriptional modifying factors. 
Ribosomal Protein S19 (RPS19) is the gene linked to Diamond Blackfan 
Anemia, the first identified ribosomopathy. Paradoxically, patients suffering 
from this disorder initially present with insufficient blood cells but later exhibit 
a proclivity toward developing hyper-proliferative blood cell formation. The 
other two most common ribosomopathies include Isolated Congenital 
Asplenia (linked to mutations in the gene encoding for RPS0) and 5q- 
syndrome (a somatically acquired haploinsufficiency of RPS14). Despite 
originating in the ribosome, the unique phenotypes that are symptomatic of 
under-developed cells and the tissue specificity of ribosomopathies are not 
compatible with ribosomal biogenesis defect etiologies. The unique clinical 
  
presentations of each of these diseases are consistent with the presence of 
“specialized” ribosomes, where each tissue type may require a certain subset 
of ribosomes. Recent studies into another ribosomopathy, X-linked 
dyskeratosis congenita (X-DC), revealed that defects in rRNA 
pseudouridylation patterns result in defects in translational fidelity. In order to 
study the translational effects of ribosomal protein haploinsufficient 
ribosomes, we used the Saccharomyces cerevisiae yeast as model for 
human ribosomopathies. Haploid yeast cells harbor two functional paralogs of 
RPS0, RPS14 and RPS19, in addition to other ribosomal proteins, due to an 
ancient whole genome duplication event. The yeast model enables the 
generation of single knockout of either the A or B paralogous ribosomal 
protein gene. Yeas also provides the ability to monitor gene specific 
differences in translational fidelity relative to isogenic wild-type cells. 
Ribosomal protein gene haploinsufficiency confers gene-specific translational 
fidelity defects. In assays that monitor recoding event frequencies, the most 
notable result was an increase in stop codon readthrough for all 
haploinsufficient strains. -1 or +1 Programmed Ribosomal Frameshift (PRF) 
recoding events were shown to exhibit isoform and sequence specific events, 
e.g. one isoform of RPS0 exhibits an increased -1 PRF recoding efficiency 
while the other demonstrates a decreased -1 PRF efficiency. Steady state 
mRNA abundance measurements reveals that RPS19 gene pseudo-
haploinsufficiency confers a global decrease in mRNA abundance. In steady 
state mRNA abundance measurements of genes involved in telomere length 
  
maintenance, RPS0 and RPS14 were shown to exhibit sequence specific 
effects, only presenting an increase in mRNA abundance for CDC13 while 
exhibiting a decrease for others. These idiosyncratic results challenge the 
prevailing notion of the “monolithic ribosome”. Here, we present a novel 
model whereby the transcriptome is translated and regulated by a 
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Chapter 1: Introduction 
Central Dogma 
The faithful conversion of genetic information into functional proteins 
responsible for sustaining life is an involved, complex, and multi-step process. 
Deoxyribonucleic acid (DNA) sequences are copied by ribonucleic acid (RNA) 
polymerases into complementary RNA sequences called messenger RNAs 
(mRNA).  These mRNAs contain the genetic information that codes for 
proteins. Translation from mRNA into functional proteins is an essential 
process which is accomplished by the largest RNA-protein complex in the 
cell, the ribosome. Ribosomes, in concert with certain trans-acting factors, 
translate mRNA sequences from initiation to termination codons into proteins. 
Ribosomes are continuously engaged in translating mRNAs with high speed 
and accuracy, bridging the genetic information and functional protein worlds. 
While ribosomes are present in cells of all kingdoms, their assembly and 
structures vary among Bacteria, Archaea, and Eukarya. These differences 
effectively gave rise to the development and use of many antibiotics. 
However, with the emergence of increasingly antibiotic resistant Bacteria and 
the discovery of viruses that manipulate the host ribosome to translate the 
viral genome, it has become critical to improve our understanding of ribosome 
mechanisms. From an engineering perspective, the ribosome can be 
perceived as a model nanomachine. Despite the differences in ribosome 





homologous components that are preserved in many species. Studies of the 
inner workings of this nanomachine provide a platform for increasing our 
understanding of the roles and functions of each component in ribosomal 
assembly and function. Defects of the ribosome and canonical translation 
have broad implications in human health including birth defects, cancer, 
neurological diseases and blood disorders. Additionally, the combination of 
the rise of bioinformatics with the increasing computational power driving this 
field and the decreasing costs of genomic sequencing has revealed a new 
class of genetic diseases: ribosomopathies. Ribosomopathies are defined as 
a class of disease in which genetic abnormalities of either ribosomal protein 
or ribosomal RNA lead to impaired ribosomal function. By studying 
genetically-linked ribosomal diseases, we can obtain a deeper understanding 
of the chemistry, structure and mechanisms of ribosomes which may result in 
more effective treatments. 
Ribosomal Anatomy 
The ribosome is universally comprised of two subunits that are defined 
by their sedimentation coefficients, S: the large subunit (LSU, 50S in 
prokaryotes and 60S in eukaryotes) and the small subunit (SSU, 30S in 
prokaryotes and 40S in eukaryotes).  The complete ribosome is defined as 
70S in prokaryotes and 80S in eukaryotes.  Each subunit has its distinct 
functions but both must coordinate together with the help of trans-acting 
factors to synthesize the proteins encoded within mRNA sequences. The 





the decoding center (DC) and the peptidyltransferase center, are conserved 
across all kingdoms of life. However, eukaryotic ribosomes are larger and 
more complex than their prokaryotic counterparts. Eukaryotic ribosomes 
possess additional rRNA segments, known as expansion segments (ES), and 
have a greater number of ribosomal proteins (79 compared to the 54 in 
prokaryotes). These increase the complexity of the ribosome and change the 
landscape of our understanding of how the ribosome works. 
The yeast 80S ribosome has four ribosomal RNAs (rRNA) (LSU, 25S, 
5.8S and 5S rRNA; SSU, 18S rRNA) and 79 ribosomal proteins (LSU, with 47 
proteins; SSU, with 32 proteins). These rRNAs and RPs are essential for 
successful ribosomal functions (1, 2). The yeast Saccharomyces cerevisiae 
80S ribosome crystal structure is shown in Figure 3. Each of the subunits 
contains an active region essential to the ribosome’s function; the SSU 
contains the decoding center (DC) which is responsible for decoding the 
mRNA sequence and accepting the transfer RNA (tRNA) only after ensuring 
the complementarity of the codon sequence on the mRNA to the anti-codon 
of the tRNA molecule. The LSU contains the peptidyltransferase center, a 
catalytically active region in which the amino acid of the incoming aminoacyl-
tRNA (aa-tRNA) is linked by a peptide bond to the elongating polypeptide 
chain. In addition, the LSU also contains the exit tunnel for the elongating 
polypeptide chain; three tRNA binding cavities; and the Sarcin-Ricin Loop 
(SRL) which is a rRNA region on the 25S that is responsible for interacting 





the aforementioned components are essential. When they coordinate with 
each other in addition to trans-acting factors, the ribosome is able to faithfully 
translate mRNAs with high speed and accuracy. This utilizes the kinetics and 
thermodynamics of these cofactors to ensure translational fidelity. 
The ribosome is a RNA-based enzyme. Ribosomal RNA has over 100 
base modifications, e.g. methylation and pseudo-uridylation (3). Ribosomal 
RNAs also utilize critical structural motifs. These include  20 of the 25 non-
canonical base-pairing motifs (4), structural motifs including tetraloops, E-
loops, U- and K- turns, purine stacks, coaxial stacking, ribose zippers, and A-
minor motifs (5). Ribosomal proteins, for the most part, contain solvent-side 
globular regions and nonsolvent-side non-globular and flexible regions that 
interact with rRNA. Originally, it was believed that ribosomal proteins were 
essential to maintain the enzymatic functions of the ribosome, and the role of 
rRNA was limited to support and structural scaffolding roles. However, more 
detailed research revealed that all catalytic activity takes place in an RNA 
based environment. Many ribosomal proteins are essential and mutations can 






Figure 1. Yeast ribosome structure. 
Both subunits are shown from the intersubunit face view (top), side view (middle) and in the 






Efficient translation requires the active regions of structurally complex 
subunits to coordinate together. This is achieved via allosteric communication 
pathways through the 17 contact points between the LSU and the SSU, which 
are known as the intersubunit bridges (9). These intersubunit bridges are 
formed through RNA:RNA interactions, RNA:protein interactions, or a 
protein:protein interaction which known the B1b/c intersubunit bridge (9). The 
locations and points of contact of these intersubunit bridges are presented in 
Figure 4. The translating ribosome undergoes large structural and 
conformational changes. The nature of these intersubunit bridges are 
variable; some bridges remain intact, e.g. (B3), while others, e.g. (B7a) and 




Figure 2. Location of ribosomal inter-subunit bridges.  
Of the 17 inter-subunit bridges, B1b/c is the only protein:protein bridge, while all others are 





These structural reconfigurations are essential for ushering transfer 
RNA (tRNA) through the translating ribosome. tRNAs are L shaped RNA 
molecules with 5 secondary and tertiary regions as shown in Figure 5.  tRNAs 
harbor 4 loops: D-loop, T-loop, the anticodon loop with a variable “extra arm”, 
and an acceptor stem with one of the 20 amino acid attached at its 3’ CCA 
end. These structural elements enable the tRNA to interact with the mRNA in 
the SSU through the anticodon loop and the peptidyltransferase center in the 
LSU through 3’-CCA end of the acceptor stem. During translation, tRNA will 
travel through the ribosome and bind/interact with three distinct regions; the 
A-site, P-site and the E-site. Aminoacyl-tRNAs are tRNAs located in the 
“acceptor” A-site while peptidyl-tRNAs reside in the “peptidyl transfer” P-site 
and deaminoacylated tRNAs leave the ribosome through the “exit” E-site 



















Figure 3. tRNA structure.  
Non base-paired regions form the 4 shown loops. The anticodon interacts with the decoding 
center in the SSU, while the acceptor stem is covalently linked to the appropriate amino acid 











Ribosome Biogenesis Overview 
A single Saccharomyces cerevisiae yeast cell can contain up to 
200,000 ribosomes distributed throughout the cytoplasm and on the rough 
endoplasmic reticulum (11). To meet the needs of an actively growing cell, up 
to 2000 ribosomes can be assembled per minute (12). In order to ensure 
production of viable and fully functional ribosomes, the biogenesis of healthy 
ribosomes must follow a stringent and sequential assembly mechanism that 
incorporates multiple quality checkpoints. Impairment or defects in ribosomal 
assembly may lead to defective ribosomes, which can result in pathological 
conditions that are generally classified as ribosomopathies (see 
Ribosomopathies: An Overview of Ribosomal Dysfunction). 
Most of our knowledge of the eukaryotic ribosome biogenesis pathway 
comes from the extensive studies of the yeast Saccharomyces cerevisiae. 
Yeast ribosomal biogenesis involves ~200 essential accessory proteins and 
trans-acting factors (13, 14). The process begins in the nucleolus, a 
specialized compartment within the nucleus (15, 16) where a 35S precursor 
ribosomal RNA (rRNA) is transcribed by RNA polymerase I. The 35S 
precursor rRNA is subjected to a series of exonucleolytic and endonucleolytic 
cleavages and base modifications, such as pseudo-uridylation and 
methylation (17), resulting in mature 5.8S, 18S and 25S rRNAs. The 5S rRNA 
is transcribed by RNA polymerase III in the nucleus, undergoes maturation in 
the cytoplasm and is transported to the nucleolus in complex with L5 and L11 





protein mRNAs in the nucleus. The RP mRNAs transported to the cytoplasm 
for translation into mature RPs and then transported into the nucleus or the 
nucleolus for incorporation into the ribosome (12). In the nucleolus, the 
ribosomal proteins are processed and assembled with rRNA, in a 
stoichiometric manner that promotes equimolar assembly into ribosomes (19), 
to form the 43S and 66S preribosomal particles. They are then transported 
into the cytoplasm by non-ribosomal trans-acting factors that prevent any 
premature ribosomal subunit interactions. In the cytoplasm, after the final 
processing and maturation steps of ribosomal biogenesis (12), the fully 
matured and assembled subunits are able to interact and form a 
























Figure 4. General Model of the Ribosomal Biogenesis Pathway 
Pathway for the maturation of preribosomes to form 40S and 60S ribosomal subunits. 
Sequential assembly intermediates are shown, distinguished by the pre-rRNA processing 










Life requires rapid and accurate protein synthesis. The ribosome is 
capable of meeting the following criteria: it synthesizes new polypeptides, 
increasing the polypeptide length by one amino acid in approximately 60 ms 
with an error rate of 1 in every 103 – 104 codon reads (21). In addition to the 
efficiency of a single ribosome, a single mRNA can contain several translating 
ribosomes, called polysomes. The translation process is divided into 4 
phases: initiation, elongation, termination and ribosome recycling; each phase 
is assisted by trans-acting factors. The initiation phase begins by assembling 
the 80S ribosome onto an mRNA strand at the appropriate start codon (AUG). 
Initiation is followed by the elongation phase, which is comprised of multiple 
elongation cycle. Each elongation cycle adds a new amino acid that 
corresponds to the codon on the mRNA to the nascent polypeptide. Between 
each elongation cycle, the ribosome will translocate along the mRNA in a 3’ – 
5’ direction. The elongation phase ends when the ribosome encounters a stop 
codon (UAA, UAG, or UGA). This triggers the termination phase and releases 
the fully formed polypeptide chain with the assistance of release factors. After 
termination, the ribosome can either reinitiate at the start of the mRNA for 









Translational initiation is a multi-step process that involves several 
trans-acting eukaryotic initiation factors (eIF). This process imposes a 
significant rate-limiting step in translation. (22). First, a mature small 
ribosomal 40S subunit (SSU) is recruited to the mRNA. Once the intermediary 
complex is localized at the appropriate start codon, the complex will then 
recruit a mature large ribosomal 60S subunit (LSU) to form a translationally-
capable 80S ribosome. The initiation process in eukaryotic ribosomes is 
shown in Figure 7 below.  
Initiation begins with the assembly of 40S SSU, eIF1A and eIF3 to 
form a complex that will prevent any premature binding of the 60S LSU (23). 
The binding of eIF3 and eIF5 to the previously mentioned complex is required 
to recruit the eIF2:GTP:Met-tRNAiMet ternary complex to form what is known 
as the 43S pre-initiation complex (24). However, before the 43S pre-initiation 
complex can bind to the mRNA, the mRNA must undergo an independent 
process that primes the message for initiation. The mRNA interacts with 
several factors, the poly adenosine binding protein (PABP) that interacts with 
both the 3’ end poly-adenosine (polyA) tail of the message and the eIF4F 
complex. The eIF4F complex interacts with the 5’ end 7-methylguanosine 
(m7G) cap. The eIF4F complex is composed of eIF4A, eIF4B, eIF4E, and 
eIF4G. This complex binds to the m7G cap via interactions with eIF4E. The 
eIF4G factor is a scaffolding factor within the eIF4 complex that interacts with 





linkage of the two ends of the message, ie. circularizing the mRNA (25). This 
closed loop provides an additional translational expression control 
mechanism via any translational regulation feature contained within the 
untranslated regions (UTRs) of the mRNA. 
The closed mRNA loop is now capable of interacting with the 43S pre-
initiation complex. The initiation factors eIF1 and eIF1A which are bound to 
the 43S pre-initiation complex, will linearize the closed mRNA loop. The 
eIF4G which is bound to the 5’ end m7G cap of the open mRNA, facilitates 
binding to the eIF3 resulting in the formation of the 48S pre-initiation complex. 
Upon binding, the initiation factors eIF1 and eIF1A, in an ATP dependent 
manner, powers the 48S pre-initiation complex to begin scanning the mRNA 
for the AUG start codon in a 5’ to 3’ direction (26). The cognate binding of the 
anticodon of Met-tRNAiMet to the AUG start codon triggers GTP hydrolysis by 
eIF2 and eIF5. This concurrently dissociates eIF2:GDP and subsequently 
dissociates all remaining initiation factors except eIF1A. This allows 
eIF5B:GTP  to recruit the 60S LSUto the SSU to form a mature 80S ribosome 
with the stable Met-tRNAiMet occupying the P-site bound to the AUG of the 
mRNA (27–29). The dissociated eIF2:GDP is then recycled by the guanine 
exchange factor (GEF) eIF2B into eIF2:GTP, reassembling the ternary 






Figure 5. Summary of the Eukaryotic Initiation.  
Known steps and factors are indicated. The GEF eIF2B is inhibited by the phosphorylation of 
eIF2 of its α subunit by various kinases, activated by different kinds of stress. Image from 





The 5’- m7G cap and the 3’ poly-A tail were thought to be essential 
structural components to successfully initiate translation. This is not the case 
as studies have detected the translation of cap-free viral mRNAs. Viruses 
have evolved cap-independent initiation mechanisms in order to become 
translationally competent. Some viruses have evolved mechanisms that 
“steal” the m7G cap (flu viruses via cap-snatching endonucleases (31)), or  
m7G cap mimics, eg. picornaviruses with VPg protein attached to the 5’ end of 
the mRNA (32, 33). Internal Ribosomal Entry Sites (IRES) represent another 
method viruses employ to initiate translation that enables the viral mRNA to 
become translationally competent without the 5’ m7G cap(34, 35). IRES-
containing mRNA possess stable secondary structures located in their 5’-UTR 
region which in some cases mimic the structure of tRNAs. These mimicked 
structures can interact with eIFs which makes them capable of recruiting 
ribosomes and initiating translation internally. IRES elements are structurally 
variable and these elements enable viruses to bypass the rate-limiting step of 
initiation which serves as a translational regulatory step. Recently, IRES 
elements have been discovered and characterized in eukaryotes (36–38). 
Cap dependent translation is compromised when the cell is under stress 
conditions. In a response to the stress condition, the ribosome will encourage 











Elongation is an iterative process that begins once the 80S ribosome is 
stabilized after initiation. During elongation, the ribosome will read the mRNA 
in the 5’ to 3’ direction, one codon at a time. With each codon, the ribosome 
must simultaneously and rapidly decode the codon, screen for and select the 
cognate tRNA, and undergo peptidyltransfer. This transfers amino acid of the 
incoming tRNA onto the growing nascent polypeptide chain. The ribosome 
will continue to elongate until it encounters a stop codon. Ribosomes must 
rely on aa-tRNAs and elongation factors (EFs) to supply the ribosome with 
the appropriate amino acid for each codon read per elongation cycle. An 
elongation cycle has 4 major stages: aa-tRNA selection, accommodation, 
peptidyl transfer and translocation. 
 
Amino-acyl tRNA selection 
At the beginning of every elongation cycle, charged tRNAs must be 
brought to the elongating ribosome. These amino-acyl tRNAs (aa-tRNA) are 
bound with eEF1A and GTP, a complex known as the Ternary Complex (TC), 
and are delivered to the A-site of the ribosome. The interaction between the 
anticodon on the aa-tRNA of the TC and the mRNA codon, shown in Figure 8, 
determines whether the aa-tRNA is accepted (accommodation) or rejected 
(40–42). This process has several distinct steps. During the initial binding, the 
ternary complex forms an internal unstable interaction between the anticodon 
loop of aa-tRNA in the A-site of the decoding center. The rest of the tRNA is 





This adopted but distorted conformation is conserved between cognate and 
near-cognate tRNAs which enables the second step. The next step is the 
codon recognition step, which regulates and stabilizes cognate and near 
cognate TCs according to their codon-anticodon Watson-Crick base-pairing 
efficiencies. Non-cognate TCs are efficiently and quickly rejected at this step, 
the first of two proofreading steps.  
After tRNA selection, the SSU 18S rRNA flips three bases (A1755, 
A1756, and G577) from a syn to anti conformation, stabilizing the aa-tRNA 
(43, 44). This stabilization induces conformational changes promoting the 
GTPase activity of eEF1A (45–47). The conversion from GTP to GDP causes 
eEF1A to undergo a conformational change, decreasing the TC’s affinity to 
the aa-tRNA. This triggers a dissociation of aa-tRNA from eEF1A:GDP 
complex and allows the accommodation of the entire aa-tRNA into the A-site 
of the ribosome. 
The conserved torsional distortion of the aa-tRNAs and codon and 
anti-codon Watson-Crick base-pairing efficiencies differences are insufficient 
for distinguishing between cognate and near-cognate ternary complexes. This 
is evident in the kinetic schematic in Figure 8 which shows that the difference 
in the reverse rate of codon recognition (k-2) and the forward rate of activation 
of GTPase (k3) is not large enough. However, due to decreased eEF1A 
activation and GTP hydrolysis rates, near-cognate aa-tRNAs dissociate at a 
much faster rate during the initial codon recognition step relative to those 





discrimination between cognate and near-cognate tRNAs in the second stage 
of accommodation, known as “proofreading”.  
The process of the second stage is not fully understood. However, 
recent evidence suggests that the stabilization of the anticodon stem loop 
(ASL) by rRNA in both subunits is due to the recognition of the geometry of 
canonical Watson-Crick base-pairing of the codon-anticodon helix in the DC 
(51). This stabilization creates a relative fixed orientation of the anticodon 
stem loop as it traverses through the accommodation corridor through a 
cascade of structural rearrangements of the LSU rRNA and ribosomal 
proteins. This induced fit mechanism promotes the binding of cognate tRNAs 
to their corresponding codons on the mRNA enabling successful movement 
through the accommodation corridor. Near-cognate tRNAs lack this 
stabilization required to traverse the accommodation corridor, resulting in the 
dissociation of the near-cognate tRNA from the ribosome (52). Kinetic studies 
show that cognate tRNAs have quicker A-site accommodation and peptidyl 
transfer rates than near-cognate tRNAs. These studies support the induced fit 
mechanism model (53). This presents the second proofreading step as a 
“kinetic filter”. The two proofreading strategies ensure the accommodation of 
correct aa-tRNAs to ribosomes through increased binding stability and 
increased efficiency during A-site accommodation and GTP hydrolysis than 










Figure 6. Scheme of tRNA selection at the ribosomal A-site 
The initial binding step in tRNA selection, governed by the rate constants k1 and k-1, is a codon-
independent reaction between the ternary complex and the ribosome, while the following 
codon-recognition step is codon dependent. The active site of the elongation factor undergoes 
a conformational change during GTPase activation. This step is pivotal for establishing the 
irreversible step essential to proofreading and appears to limit the rate of GTP hydrolysis. 
During the proofreading stage after factor dissociation the tRNA either moves into the A-site 
(accommodation) for peptidyltransfer or dissociates from the ribosome (rejection). 
Accommodation is regulated by the rate constant k5 and depends on codon-anticodon 











Peptidyl transfer occurs after accommodation. It occurs in the 
peptidyltransferase center of the LSU which is solely responsible for peptide 
bond synthesis. The peptidyltransferase center is the catalytic core of the 
ribosome and is comprised entirely of rRNA. The nearest ribosomal protein is 
13 angstroms away (9).  Upon accommodation, the aa-tRNA is stabilized 
within the ribosome, with the 3’-CCA end in the peptidyltransferase center of 
the A-site of the LSU and the anticodon loop in the DC of the A-site of the 
SSU, as shown in Figure 9. Once properly positioned, the 3’-CCA end of the 
aa-tRNA is stabilized by the 25S rRNA into the peptidyltransferase center. 
The peptidyl transfer reaction between the α-amino group of the aa-tRNA and 
the ester linkage of the peptidyl-tRNA is then catalyzed. During the peptidyl 
transfer, the α-amino group of the A-site aa-tRNA carries out a nucleophilic 
attack on the carbonyl carbon of the ester bond that links the peptide chain to 
the P-site peptidyl-tRNA (54). This results in the deacylation of the P-site 
peptidyl-tRNA and transfers the nascent peptide to the A-site aa-tRNA. The 
peptidyl transfer reaction occurs nearly instantaneously; less than 50 ms (46). 
This speed is due the ability of amines intrinsically linking esters to form 
peptide bonds at rates of ∼10−4 M−1 s−1 at room temperature in addition to the 













Figure 7 Mechanism of peptidyltransfer. 
The α-amino group of the aminoacyl tRNA in the A site attacks the carbonyl carbon of the 
peptidyl-tRNA in the P site. The universally conserved bases in green, among others, 
promote electrostatic shielding and a concerted proton-shuttle mechanism resulting in 
stabilization of a six-membered transition state and facilitating catalysis. Figure modified from 








After peptidyl transfer, the ribosome must translocate in order to prime 
for the next elongation cycle. During the translocation process, the A-site is 
vacated to prepare for the next ternary complex and the ribosome moves 
downstream the mRNA strand to the next codon. In order to vacate the A-site, 
the bound aa-tRNA and deacylated tRNA ligands in the A- and P-sites must 
be shifted into the P- and E-sites, respectively. This shift from one site to 
another is driven by the GTP hydrolysis of the eEF2:GTP complex. The 
tRNAs that undergo translocation will adopt specific ligand repositioning 
conformations which are known as classical and hybrid states as shown in 
Figure 10. The aa-tRNA and deacylated tRNA are in the classical A/A and 
P/P states (nomenclature refers to the tRNA position in the SSU/LSU) which 
shifts into the hybrid A/P and P/E states (58–60). This hybrid configuration is 
only possible after the deacylation of the peptidyl tRNA, likely due to the 
anchoring effect of the attachment of the peptidyl tRNA to the polypeptide 
chain in the exit tunnel (61). The repositioning of tRNA from the classical into 
the hybrid state requires movements of tRNAs. Unlike the P-site tRNA which 
has large movements of the D-loop, T-loop, and the CCA end; the A-site 
tRNA only has its CCA end repositioned into the P-site of the LSU (62).  The 
ternary complex mimic, eEF2, binds to both subunits and through GTP 
hydrolysis, drives translocation. After translocation, the ribosome returns to 





downstream and transfers the tRNAs bound to the SSU A- and P- sites to 






Figure 8. Positions of tRNAs transitioning between the classical and 
hybrid states during translation.  
The relative position of tRNAs during classical, hybrid, and pre-accommodation states. Figure 










The transition between the classical and hybrid states is only 
accomplished through a dynamic structural rearrangement of the ribosome. 
This dynamic movement, once referred as “ratcheting”, is now considered a 
“rotation” due to the 6o rotation of the SSU in a counterclockwise direction 
relative to the LSU as shown in Figure 11 (66–69). The ribosomal 
conformation due to rotation determines the state of the ribosome, i.e. 
unrotated ribosomes exist in the classical state while rotated ribosomes exist 





Figure 9. Ribosomal intersubunit rotation. 
Subtle rotation of the SSU relative to the LSU during translation. Image modified from 







When the DC of the elongating ribosome encounters one of the three 
stop codons (UAA, UAG, UGA) signifying the end of the ORF of the gene, it 
then enters the termination stage. These codons are also known as nonsense 
codons and do not have a correlating cognate tRNA (70). Instead, these 
codons are recognized and bind to eukaryotic release factors (eRFs) when 
the A-site of the ribosome is positioned in-frame to one of the stop codons 
and triggers a hydrolysis reaction which results in the release of the 
polypeptide chain from the tRNA in P-site of the ribosome. In eukaryotes, an 
omnipotent class I eRF (eRF1) can recognize all three stop codons and will 
bind to the stop codon in the A-site. Prior to binding to the ribosome, eRF1 
will form a complex with class II RF (eRF3) and GTP (71–74). This 
eRF1:eRF3:GTP complex is a molecular mimic of the aa-tRNA Ternary 
Complex as shown in Figure 12. The structural mimicry also suggests that the 
two complexes employ similar mechanisms to bind to the ribosome (67). 
Binding of these RFs induces similar conformational changes of the ribosome 
as those during peptidyl transfer in the elongation stage. The only difference 
between the two stages is that during elongation, the ribosomal 
peptidyltransferase center is constructed in a conformation that precludes the 
presence of water in the peptidyltransferase center. This serves to reduce the 
possibility of premature polypeptide hydrolysis. The second difference occurs 
during termination, in which the GQQ motif of the eRF1 will induce structural 
rearrangements that enables appropriate hydrolysis and release the peptide 







Figure 10. Molecular Mimicry of tRNA:  structures of yeast eRF1 and 
tRNAPhe. Eukaryotic release factors are biological mimics of tRNAs, structurally and 




Figure 11. Crystal Structures of translational factors that mimic tRNA 
Several examples of how ribosomal factors are biological mimics of each other, suggests that 
translation is a kinetic partitioning process where side reactions can compete during altered 






As peptide release occurs, the ribosome is still bound to the mRNA 
with an deacylated tRNA and eRF in the P- and A-sites, respectively. Recent 
studies suggest that ABCE1 (an ATPase) promotes ribosomal subunits 





Figure 12. Model of the eukaryotic translation termination 
Recognition of the stop codon recruits the eRF1:eRF3:GTP complex to the ribosomal A-site. 
eRF3 is a G-protein. This is followed by the binding of ABCE-ATP to the release factor complex. 
Subsequent GTP and ATP hydrolysis results in release of the ribosomal subunits from the 















Canonical protein synthesis begins at the AUG start codon and 
continues in-frame through the open reading frame (ORF) one codon at a 
time until terminating at a stop codon which results in a single protein product. 
The ribosome can also take other non-canonical translational pathways which 
are generally known as “translational recoding events”. These result in 
alternative protein products due to the alteration of the open reading frame 
post initiation or suppression of termination codons. While changes in 
translational reading frame maintenance and termination codon redefinition 
are intrinsically rare, occurring at a rate of 10-4 to 10-6  (78) recoding events 
occur at 10 – 100 fold greater frequencies through stimulation by mRNA cis-
acting elements. Historically, such recoding events were first identified in 
viruses which have a demonstrated need for increased information content in 
a condensed genetic space. However, these recoding events have been 
identified in prokaryote and eukaryotic organisms (79). These discoveries 
demonstrate a need for greater understanding of the translational machinery 
which will lead to insights into how defective ribosomes differ from healthy 










Programmed -1 Frameshifting 
Programmed -1  Ribosomal Frameshifting (-1 PRF) is a non-random 
recoding event that induces the elongating ribosome to shift “backwards” (in 
the 3’ direction) by one nucleotide on an mRNA, directing the ribosome to a 
new open reading frame (ORF). The elongating ribosome continues in this 
ORF to generate an alternate protein product. This type of recoding event 
allows the synthesis of multiple protein products from a single message; a 
genomic condensation strategy that is employed by viruses that have a need 
to maximize their genomic informational content because their genomic sizes 
are limited by the volumes of their nucleocapsids. The first -1 PRF recoding 
event was discovered in the Rous Sarcoma Virus (RSV), a retrovirus (80). 
Subsequently, -1 PRF signals have been identified in other retroviruses, 
alphaviruses (81), astroviruses (82), coronaviruses (83, 84), luteoviruses and 
totiviruses, (reviewed in database(85)). The large number of viruses 
employing -1 PRF has allowed elucidation of the parameters and rules 
governing this recoding event. 
 A -1 PRF signal requires three important mRNA elements: a 
heptameric slippery site, a spacer region of 0 to 12 nucleotides, and a 
downstream stimulatory mRNA tertiary structure, e.g. a pseudoknot or a stem 
loop (86–90). Figure 15 shows a model of the mechanism of the -1 PRF 
recoding event.  The heptameric slippery sequence follows the 5’-XXXYYYZ-
3’ format where X can be any three identical bases, Y is any three identical 





stimulating structure is thought to cause the ribosome to stall upon encounter. 
If the ribosome stalls when positioned at the slippery site, a  where the P- and 
A-site tRNAs are matched in the 0-frame with the XXY and YYZ codons 
respectively (92). This positioning increases “slippage” due to the sequence 
enabling re-positioning/re-pairing of the non-wobble base pairs of the aa-
tRNA and peptidyl-tRNAs with the -1 frame codons. The frequency of 
“slippage” is primarily determined by the number of A/U nucleotides within the 
heptameric slip site. A/U nucleotides form weaker Watson-Crick base-pairs 
strength relative to G/C nucleotides. If there are more A/U nucleotides than 
G/C nucleotides in the slip site, the ribosome will slip more frequently. The 
slippery site alone does not confer biologically relevant -1PRF recoding, only 
occurring at a rate of approximately 0.1 – 0.2% in mammals (93, 94). 
However, the combination of the slippery site and the downstream tertiary 
structure (e.g. a pseudoknot) increases -1 PRF recoding rates to biologically 
significant rates due to the stalling of the ribosome as it attempts to resolve 
the obstructing structure upon encounter (95). Concurrently, the energetic 
barrier of the pseudoknot can be overcome and as the ribosome shifts in the -
1 ORF, the tertiary structure is resolved and the ribosome resumes elongating 
in the new -1 reading frame. RNA structural elements that attenuate 
frameshifting/recoding events are also known (96). The molecular mechanism 
of -1 PRF is not just one particular mechanism. While several competing 
models attempted to pinpoint the exact time and mechanism for the shift out 





achieved through several different kinetic pathways. This is known as  the 





Figure 13. Structure of a -1 PRF signal on an mRNA.  
The slippery site, where the A- and P-site tRNAs are positioned and the shift in frame occurs, 
is denoted by IUPAC notation (N = any 3 identical nucleotides, W=AAA or UUU, and N≠G). 22 
functional slippery sites are known. While a pseudoknot is the most common type of stimulatory 


























Figure 14. Structure and Mechanism of a -1 PRF. 
The elements of a -1 PRF signal include a slippery heptamer of the form NNNWWWH (IUPAC 
notation), a spacer and a downstream mRNA tertiary structure which is usually an H-type 
pseudoknot. A frameshift event occurs during the ribosomal pause when a translating ribosome 
encounters downstream tertiary structure, usually a pseudoknot. This creates tension along 
the spacer which is relieved by a shift of one base, where by the P- and A- site codons at the 







In addition to enhancing genomic content, -1 PRF recoding events also 
serve to control the relative stoichiometric ratios of gene products. The L-A 
virus, as shown in Figure 17, depends on the stoichiometry of two products in 
a 60:1 ratio: Gag and Gag-Pol. Gag codes the viral capsid and Gag-Pol 
codes for the viral replicase. The stoichiometric ratio is essential for efficient 
proliferation of the virus (84, 99). Disrupting the -1 PRF recoding signal by 
mutation or any other means leads to inefficient viral proliferation due to the 
deviation from the stoichiometric ratio of Gag and Gag-Pol (91). Discoveries 
in yeast have further supported the premise that -1 PRF recoding events, via 
regulation through stoichiometry of gene products, can have biological 
implications. In the case of Saccharomyces cerevisiae, the function of the 
telomere length maintenance complex is regulated by the stoichiometry of the 
products of CDC13, EST1, EST2, EST3 and STN1. All of the aforementioned 
genes, except for EST3, the mRNA of which contains a +1 PRF signal, are 
encoded by messages that contain -1 PRF signals. Studies in which the -1 
PRF recoding rates are altered via mutations in either the slippery site or 












Figure 15. Viral genomic organization and gene expression regulation 
via -1 PRF 
The figure shows a schematic of -1 PRF signals in L-A, HIV-1 and SARS genomes. The overlap 
regions highlighted by the rectangles harbors the -1 PRF signals. These sequences on the 
mRNA stochastically shift reading frame of the elongating ribosome and translate a fusion 
protein. Thus we have a scenario where the virus is able to coopt the host’s translational 
machinery to get a specific ratio of two protein products from a single transcript. An increase 
or decrease in the frameshifting rate results in improper virion assembly and generates a non-





A growing number of eukaryotic mRNAs have been identified that 
contain functional -1 PRF signals that serve as a means to regulate gene 
expression (101–104). Nearly all known cellular -1 PRF recoding events shift 
the elongating ribosome into -1 ORFs that contain premature termination 
codons (PTC). Studies using endogenous -1 PRF signals from yeast show 
that -1 PRF signals function as mRNA destabilizing elements through 
Nonsense Mediated Decay (NMD), and No-Go Decay (NGD) pathway (105, 
106). As -1 PRF directs the ribosome to a PTC and stimulate NMD, this 
mechanism leads to an inverse correlation between -1 PRF recoding 


























Programmed +1 Frameshifting 
Programmed +1 Ribosomal Frameshifting (+1 PRF) is another mode of 
recoding that functions biologically similarly to -1 PRF by directing ribosomes 
to shift the translational frame, but by 1 nucleotide forward, i.e. in the 3’ 
direction. This class of recoding event can result in either a premature 
termination or synthesis of a larger fusion protein due to the bypassing of the 
0-frame stop codon. There are fewer known signals that induce a +1 PRF 
recoding event relative to the number of signals known to induce -1 PRF. +1 
PRF signals are employed by viruses and transposable elements in a variety 
of organisms’ genomes (ie. human, mouse, yeast, bacteria) to synthesize 
structural and enzymatic proteins (28, 107–109). In order for a +1 PRF 
recoding event to occur, it requires the presence of a heptameric slippery site. 
The downstream RNA tertiary structure is optional for +1 PRF recoding 
events. 
Ty1 and EST3 are both mRNAs that contain known +1 PRF signals 
and lack a downstream RNA tertiary structure. Ty1 is a retroviral like 
retrotransposon in yeast where a +1 PRF recoding event results in synthesis 
of a Gag-pol fusion protein. A Ty1 +1 PRF recoding event requires the 
following: a heptameric slippery site, a near-cognate aa-tRNA bound to the P-
site, an empty A-site where the mRNA 0 frame codon encodes for a rare 
tRNA and the codon in the +1 frame of the mRNA encodes for an abundant 
tRNA (110). In this circumstance, in lieu of a downstream stimulatory 





elongating ribosome due the inherent low abundance of the rare tRNA in the 
cell (111). If the ribosome pauses on the requisite heptameric slippery site, it 
will result in weak Watson-Crick base pairing of the tRNA in the P-site. Should 
the codon in the +1 frame specify for a tRNA species that is in greater 
abundance than the 0 frame codon, the P-site tRNA will then reform stable 
base pairing in the +1 frame with assistance from the accommodation of the 
abundant tRNA species. At this point, the ribosome resumes elongating in the 
+1 frame. EST3 is a gene that encodes for a component of the yeast telomere 
telomerase holoenzyme complex. EST3 also contains a +1 PRF signal 
between its two open reading frames (ORF1 and ORF2). When a +1 PRF 
recoding event occurs, in a manner similar to that of Ty1, it results in the 
translation of the full length EST3p (112, 113).   
 OAZ1 is an example of a message that utilizes a downstream RNA 
tertiary structure to induce a +1 PRF recoding event. OAZ1 is a yeast gene 
that encodes for an ornithine decarboxylase antizyme that regulates 
polyamine biosynthesis by degrading ornithine decarboxylases. The elements 
required to induce a +1 PRF recoding event in OAZ1 are high levels of 
polyamines, a heptameric slippery site ‘UCC UGA U’ and a downstream 
tertiary structure to induce a ribosomal pause. These factors will stimulate the 
+1 PRF event that consequently results in the synthesis of the full length 






Missense and Nonsense Suppression 
As the ribosome has evolved to rapidly and accurately decode 
mRNAs, translational fidelity is not only defined by the frequency of 
frameshifting recoding events but also by the intrinsic incorporation of 
missense and nonsense codons. Thus, we have addressed two additional 
aspects of translational fidelity utilized in this work; missense incorporation 
(the rate at which near or non-cognate tRNAs are erroneously accommodated 
and their amino acids incorporated in the growing nascent peptide chain); and 
nonsense suppression (the rate at which stop codons are not recognized or 
are translated using a suppressor tRNA). Both recoding events undermine the 
accuracy of the ribosome and, in the case of nonsense suppression, have a 
significant impact on protein synthesis.  
Nonsense suppression (also called stop codon readthrough), refers to 
the rate at which suppressor tRNAs are incorporated at stop codons. Cis-
acting elements such as mRNA pseudoknots and the identity of the 
nucleotide immediately downstream of the stop codon can also affect the 
accuracy of stop codon decoding (117–119). Selenocysteine incorporation at 
a UGA codon is a well-studied mechanism of programmed stop codon 
redefinition. This  programmed event requires a selenocysteine incorporation 
signal (SECIS) downstream of the UGA stop codon, in the 3’-UTR region 
(120) . The SECIS is recognized by a specialized elongation factor SelB that 
delivers the tRNASec to the A-site and in the case of eukaryotes requires 








Figure 16. Mechanism of Selenocysteine incorporation. 
The diagram shows the general mechanism of selenocysteine incorporation at UGA in both 
prokaryotes and eukaryotes. Selenocysteine incorporation in prokaryotes requires specialized 
elongation factor SelB and selenocysteine incorporation signals (SECIS) immediately after the 
stop codon. In eukaryotes the SECIS is located in the 3’ UTR and the selenocysteine 
incorporation requires an additional accessory protein SBP2. This figure is from (113). 
 
 
Programmed nonsense suppression is another method used in both 
viruses and eukaryotes to regulate gene expression. The murine leukemia 
virus (MuLV) utilizes a ribosomal pause induced by a strong pseudoknot 
which enables the reverse transcriptase to interact with eRF1. This reduces 
its availability to be used during ribosomal termination (123, 124). The 
reduced availability of eRF1 promotes an increase in frequency of stop codon 
readthrough (125). Recent studies in angiogenesis show the expression of an 
anti-angiogenesis factor, VEGF-Ax, is regulated through programmed stop 









Translational Recoding and mRNA abundance 
Quality assurance is an important component of translation. If a 
message should contain defects, it could result in the translation of a protein 
that may have deleterious downstream biological effects. Recoding events 
often lead the ribosome to an aberrant message scenario, e.g. a -1 PRF may 
direct the ribosome to an alternate reading frame which contains a premature 
termination codon (PTC) prior to the bona fide 0 frame stop codon. Messages 
that contain recoding elements can be intentional, functioning as a 
mechanism to maintain cellular homeostasis by regulating gene expression. 
However, translating ribosomes must have the ability to identify aberrant 
messages and efficiently eliminate them from the transcriptome. There are 
mechanisms in place so that when aberrant messages are identified, they are 
directed to one of the three decay pathway that will eliminate the message 
from the transcriptome. The three known mRNA surveillance/decay pathways 
that have evolved to monitor mRNA quality are: the Nonsense Mediated 
Decay (NMD), No-Go Decay (NGD) and Non-Stop Decay (NSD). 
Nonsense Mediated Decay (NMD) Pathway 
The NMD surveillance pathway primarily monitors and degrades 
messages that harbor premature termination codons (PTC) (127–130). In 
addition to -1 PRF recoding elements, the NMD surveillance pathway can be 
triggered by transcripts that contain nucleotide mutations, splicing errors, and 





Upf1, Upf2 Upf3 are proteins that form a complex that is essential for 
the NMD pathway of the yeast Saccharomyces cerevisiae (134). The Upf 
complex interacts with the release factors that are drawn to the ribosome as it 
recognizes a stop codon distal from the polyA tail. In this distal location, the 
release factors are able to associate in the absence of Pab1. This absence 
enhances recruitment of Upf1 to the eRF1-eRF3 complex (135). Upf2 and 
Upf3 then bind to Upf1 forming the Upf1:Upf2:Upf3 complex which is bound to 
the ribosome through the interactions between Upf1 and RPS26 (136). 
Activation of Upf1 is triggered by the formation of the Upf complex which then 
causes the release and degradation of the nascent polypeptide. eRF3 is 
dissociated from the termination complex (Figure 19). The large subunit then 
dissociates from the small subunit which remains associated with the mRNA. 
At this point, Upf1 recruits the decapping enzyme complex which destabilizes 






Figure 17. General model of NMD in yeast. 
NMD is triggered by the recognition of the premature termination codon by the termination 
complex in yeast and binding of Upf1. In context of PTC the absence of Pab1p in the vicinity 
promotes the association of Upf1 with the termination complex. Subsequent activation of Upf1 
causes peptide release, ribosomal subunit dissociation and activation of downstream mRNA 







The relationship between -1 PRF and NMD in Cellular Gene Expression 
Only 0.07% of the messages in the human genome that contain a 
predicted -1 PRF signal are able to extend beyond 30 codons (98). This 
indicates that >99% of predicted -1PRF events of human mRNAs will direct 
ribosomes to PTCs and initiate NMD. Prior studies have shown an inverse 
correlation between -1 PRF efficiencies and mRNA abundances and that 
ablation of a component of the NMD pathway stabilizes mRNA abundances in 
yeast (106), as shown in Figure 17. The induction of factors that alter 
frameshifting by reducing -1 PRF efficiencies stabilizes the mRNA abundance 
in both yeast and humans (100, 139).  This highlights the relationship 
between frameshifting/NMD efficiencies and mRNA abundances. Mutations 
that affect the translational fidelity of the ribosome, thus altering the frequency 
by which the ribosome undergoes a recoding event can have biological 
implications. These have been exemplified in the translation of yeast telomere 
maintenance genes which require a stochastic ratio to maintain telomere 
length. Altered -1 PRF efficiencies due to mutations of the ribosome, have 

















Figure 18. Delineation of mathematical relationships between -1 PRF 
and mRNA abundance in wild-type (panel A) and NMD-deficient cells 
(panel B) 
Panel A demonstrates that the mRNA abundance of a transcript containing a -1 PRF signal is 
inversely correlated to the efficiency of -1 PRF due to redirecting the ribosome to a premature 
termination codon in the -1 frame, eliciting the NMD pathway. Panel B exhibits a comparision 
of the mRNA abundance of messages containing -1 PRF signals between NMD-deficient yeast 







Figure 19.  Model of -1 PRF dependence on NMD. 
For genomic frameshift signals an elongating ribosome is directed to a -1 frame premature 
termination codon after as frameshift event. The recognition of the PTC by the ribosome results 
in activation of NMD and subsequent degradation of the frameshift signal containing mRNA. 





No-Go Decay (NGD) Pathway 
The NGD pathway degrades messages that cause ribosomes to stall. 
Ribosomal stalling can be induced by RNA tertiary structures, rare codons or 
poly-lysine sequences (140, 141). The mechanism of NGD is not fully 
understood for ribosomes that stall mid-message. Once the ribosome stalls, 
the NGD pathway begins with an endonucleolytic activity near the stalled site 
by the Dom34/Hbs1 complex (140, 142, 143). The complex then dissociates 
from the stalled ribosome on the 3’ end of the mRNA and stimulates the 3’-to-
5’ mRNA degradation by exosomes. The mechanism of NGD for ribosomes 
that stall at the 3’ end of messages at the polyA tail is indistinguishable from 
the mechanism of NSD and is described in the section below. 
Non-Stop Decay (NSD) Pathway 
The NSD pathway monitors and degrades messages that lack stop 
codons. The NSD pathway is triggered once the ribosome reaches and stalls 
at the 3’ end of the mRNA without encountering a stop codon. Substrates of 
NSD may contain processing errors where polyadenylation occurs 
prematurely within the mRNA coding region or mRNAs with truncated 3’ 
UTRs (144, 145). The mechanism by which transcripts that lack stop codons 
are degraded is not fully understood. It is thought that as the ribosome 
continues to translate to the 3’ polyA tail of the mRNA and that the ribosome 
stalls due to the multiple lysines encoded by the AAA codon. The stalled 
ribosome is recognized and associates to the C-terminus domain of the Ski7p 





(145). The bound Ski7p then recruits the exosome and Ski2p, Ski3p, and 
Ski8p, which forms the Ski complex. This triggers a 3’-to-5’ degradation of the 
nonstop transcript (145, 146). However, mRNA degradation by endonuclease 
activity alone was shown to be insufficient to inhibit protein synthesis. 
Nonstop mRNAs can contain polyribosomes on the message, and studies 
show that the presence of these polyribosomes can inhibit ribosomal 
translation (147). In support of the endonucleolytic degradation of the mRNA, 
the proteasome has been implicated in assisting the degradation of the 














Ribosomopathies: An Overview of Ribosomal Dysfunction 
Substandard cellular functions are caused by abnormal protein 
synthesis. Defective protein synthesis can be due to either ribosomal 
translational fidelity defects or altered gene expression. Deficient cellular 
homeostasis due to aberrant protein translation highlights the need to 
understand the source of these deleterious proteins: the ribosome. This class 
of disorders is categorized as ribosomopathies. They are rare diseases 
characterized by hypo-proliferative phenotypes, e.g. bone marrow failure, 
anemia, dystosis. Recently, they have been associated with the tumor 
suppressor protein p53 pathway (149). Table 1 lists several recognized 







































RPSA  (RPS0 in 
yeast) 
(mutations) 






















abnormalities (e.g. skin 
pigmentation and nail 
changes) 
Pulmonary fibrosis 














Table 1: Clinical characteristics of different ribosomopathies 







Are ribosomopathies just a ribosomal biogenesis problem? 
Ribosomopathies are a class of congenital diseases caused by 
ribosomal dysfunction due to functional and structural defects within the 
ribosome. Studies have attempted to probe and understand the underlying 
causes of the ribosomal dysfunction. At a first glance, ribosomopathies 
appear to present a direct causal link between mutations in a gene encoding 
for a ribosomal factor and haploinsufficiency of the factor leading to ribosomal 
dysfunction. Haploinsufficiency is a state in which a diploid organism has a 
single functional copy of a gene while the other is inactivated by a mutation, 
and the organism does not produce enough of the gene product to maintain 
the wild-type condition. Ribosomopathies caused by haploinsufficiency for 
ribosomal factors are often deficient in factors involved with ribosomal 
biogenesis. For example, X-linked dyskeratosis congenita (X-DC) is caused 
by a mutation in the DKC1 gene which encodes dyskerin, a protein involved 
with post-transcriptional pseudouridylation of uridines present in ribosomal 
RNA (151).  Diamond-Blackfan Anemia (DBA) Isolated Congenital Asplenia 
(ICA) and 5q- syndrome (5q-) are all caused by mutations in genes that 
encodes for ribosomal proteins (RP) S19, S0 and S14 respectively. RPS19, 
RPS0 and RPS14 are all involved in rRNA processing (152). DBA, ICA and 
5q- are all considered to be haploinsufficiency-caused ribosomopathes since 
all exhibit decreased amounts of their respective ribosomal protein.  
Attributing defects in ribosomal biogenesis as the underlying pathology 





quantity does not account for the tissue specificity of ICA (spleen) or DBA and 
5q- syndrome (bone marrow). In the case of congenital ribosomopathies, 
every cell of the body contains the same genetic mutation and not all tissues 
exhibit symptoms of ribosomal dysfunction. It is worthy to note that some of 
these ribosomopathy disorders are symptomatic of tissue developmental 
defects, e.g. a lack or severely underdeveloped spleen in ICA patients and 
defects in the development of progenitor red blood cells in the bone marrow 
of DBA and 5q- patients. A recent study has shown that hematopoiesis of 
stem/precursor cells are regulated by Nonsense Mediated Decay (NMD), 
(106, 153). NMD is a mRNA decay pathway triggered by recoding events that 
redirect the ribosome to alternate reading frames, resulting in the translation 
of an alternate protein. NMD is a process that relies on the translational 
fidelity of the ribosome which, if altered, can up or down regulate gene 
expression (154, 155). If the maturation of red blood cells is dependent on a 
process that is regulated by translational fidelity, then “dysfunctional” 
ribosomes with altered translational fidelities will hinder the development of 
mature red blood cell. Studies in the structure and function of yeast RPs have 
shown that mutations in genes encoding for RPs exhibit translational fidelity 
defects (156–158). Mutations of Cbf5, the yeast homolog of DKC1, are known 
to cause ribosomal translational fidelity defects (159). The tissue specificity of 
ribosomopathies may be linked to the responsible ribosomal factor having 





an extra-ribosomal function, e.g. regulating transcription or enzymatic activity 
(160). 
Ribosomopathies can present paradoxical effects, e.g. ribosomopathic 
patients that exhibit opposing phenotypes: several disorders are 
characterized by a hypo-proliferative phenotype, e.g. anemia, which then 
converts to a hyper-proliferative phenotype, i.e. cancer. This transition from 
hypo-proliferative to hyper-proliferative phenotype is not well understood. 
However, the current hypothesis is that these ribosomopathic ribosomes are 
still capable of translating messages, to a degree, but are dysfunctional 
enough that translational fidelity is affected which alters gene expression and 
in a domino-like manner, generates an accumulative effect. This 
accumulation invariably cumulates in the phenotype associated with the 
ribosomopathy. Cancerous tumors are associated with enhanced ribosomal 
biogenesis, increased translation rates, and in some cases, the 
overexpression of RPs (161). However, due to the nature of haploinsufficient 
ribosomopathies, RPs are underexpressed. 
The preponderance of evidence indicating defects in translation and 
the subsequently altered gene expression in ribosomopathies is suggestive of 
specialized ribosomes. It is hypothesized that specialized ribosomes are the 
result of heterogeneity in ribosome composition. The variation in ribosomal 
composition may be a consequence of differential expression and post-
translational modifications of RPs, rRNA base modification and the activity of 





may affect the translation of genetic material. As studies in ribosomopathies 
continue to reveal translational fidelity defects that alter cellular gene 
expression, it becomes more important to understand what these ribosomes 
actually do, rather than attributing the pathogenesis of the disease simply to a 
lack of ribosomes.  It stands to reason that the pathogenesis of 
ribosomopathies would be better understood by exploring and treating each 
ribosomal factor linked to their respective ribosomopathies as a unique set of 
circumstances that cumulatively presents a translational pattern that leads to 
the disease’s phenotype. 
Diamond-Blackfan Anemia: RPS19 Gene Haploinsufficiency 
Diamond-Blackfan Anemia (DBA) is a rare genetic disorder that is 
identified primarily by hematological features. It is a congenital bone marrow 
failure syndrome that results in erythoid aplasia. However, DBA does exhibit 
non-hematological features in 20% of patients. These include defects in the 
cranio-facial region, eyes, neck, thumb, urogenital tract, heart, and 
musculoskeletal structures, in addition to increased incidences of acute 
myeloid leukemia (AML) and osteogenic sarcoma (162–165). 
DBA was first reported to be associated with gene mutations in the 
ribosomal protein S19 (RPS19) gene locus on chromosome 19q13.2, which is 
mutated in about 25% of patients (166–168). Recently, mutations in other 
genes that encode for RPs in both the large and small ribosomal subunits 





DBA are not limited to ribosomal proteins but also include TSR2 (a protein 
involved in pre-rRNA processing) and GATA1 (an erythroid transcription 
factor)  (174–176). A variety of RPS19 mutations, e.g. whole gene deletions 
and truncation mutations have been observed, all of which suggests that 
haploinsufficiency is the basis of DBA pathology (166). Haploinsufficiency of 
RPS19 as the pathogenesis of DBA was further supported by the introduction 
of RPS19 in CD34+ bone marrow cells and in murine models (177, 178). 
Mutations in RPS19 are more often associated with bone marrow failure 
resulting in anemia. Mutations in other ribosomal protein genes are linked to 
other phenotypes, e.g. heart and craniofacial malformations are strongly 
associated to mutations in ribosomal proteins L5 and L11 (173). Clinically, 
RPS19 linked DBA exhibits a normochromic (normal concentration of 
hemoglobin within red blood cells) and macrocytic (enlarged red blood cells) 
anemia and a normocellular bone marrow but with decreased or absent 
erythoid precursor cells. DBA exhibits a relationship between ribosomal 
functions and erythroid aplasia. Its etiology is currently not well understood, 
however it is generally thought to be a biogenesis defect of the ribosome due 
































Table 2: List of Ribosomal Proteins associated with Diamond Blackfan 
Anemia 
Table adapted from (162). 
 
Ribosomal protein S19 is one of the 33 ribosomal proteins in the 40S 
subunit of the ribosome. RPS19 is a 144 amino acid long protein (MW ~16 
kDa) located at the head region of the small subunit of the ribosome, 
highlighted in yellow in Figure 2. RPS19 is encoded by two paralogous genes, 
RPS19A (YOL121C) and RPS19B (YNL302C). The two paralogous genes 
differ by a single amino acid (Figure 1) 
Gene Associated to 



















Figure 20. Blast Alignment of Ribosomal Protein S19 paralog A 
(YOL121C) vs B (YNL302C). 
Protein Alignment was obtained via Blast (181). 
 
 In addition to its role in improving translational efficiency, RPS19 has 
been linked to several steps in ribosomal biogenesis: rRNA processing, 
ribosomal assembly, and polypeptide assembly (182, 183). RPS19 is 
responsible for recruiting factors, Enp1, Tsr1, and Rio2 for pre-RNA 
processing. These recruited factors are essential in pre-RNA processing and 
maturation of the precursor 40S particle during the cleavage at site A2 within 
ITS1 step (as shown in Figure 3) and the subsequent maturation of the 3’ end 
of the 18S rRNA in yeast cells (152, 184–186). The diminished abundance of 
mature 18S rRNA leads to diminished levels of 40S and mature 80S 
ribosomes (187, 188). The diminished levels of 40S may also, in part, be due 
to RPS19 mutations  promoting increased nucleolar mislocalization and 
defective in its’ self-incorporation into the 40S subunit during ribosomal 
assembly (152, 189, 190). The failure to mature the 40S subunit may not be 
solely attributed to RPS19 haploinsufficiency of RPS19 but rather a loss of 





interact with Pim1, an oncoprotein, suggesting a potential physical linkage 
between signal transduction pathways and the ribosome (191).  
 
 
Figure 21. Locations of ribosomopathy associated ribosomal proteins in 
the Saccharomyces cerevisiae 40S subunit.  
The left image shows the 40S subunit from the cytoplasmic face and the right image shows the 
40S subunit in the intersubunit face. RPS19 is highlighted and circled in yellow, RPS14 in green 
and RPS0 in red. Image was modified from Ben-Shem using Pymol (8, 9). PDB accession 













Figure 22. Ribosomal rRNA synthetic pathway in Humans 








Isolated Congenital Asplenia: RPSA/yRPS0 Gene Haploinsufficiency  
Isolated Congenital Asplenia (ICA) is a rare genetic disorder caused by 
mutations in human ribosomal protein SA (RPSA). This disease is 
characterized by a lack of or severely under developed spleen while 
demonstrating no other developmental defects (192, 193). However, defects 
in spleen development puts patients at high risk for pneumococcal sepsis 
(194, 195). While the pathogenesis of ICA is not fully understood, studies 
show that mutations in the RPSA gene that generate premature termination 
codons directs the message to the NMD pathway. This results in 
haploinsufficiency of the RPSA locus (193). It is interesting that 
haploinsufficiency of RPSA alone presents a defective spleen development 
phenotype, given that RPSA is not associated with spleen development. 
Spleen development, in murine models are regulated by a cascade of 
transcription factors (i.e. Tlx1 and Pbx1) (196, 197). RPSA has a role in the 
rRNA processing of the 18S precursor rRNA. Studies have shown that siRNA 
knockdown of RPSA correlates to diminished levels of mature 18S rRNA, 
demonstrating ITS1 cleavage/processing defects in humans (198). The 
processing of the 18S precursor rRNA by ITS1 cleavage at the A2 site is 
conserved between RPSA (humans) and RPS0 (yeast) (199). While 
RPSA/RPS0 function of 18S rRNA processing may be conserved between 
humans and yeast, lymphocytes of ICA patients do not exhibit any pre-rRNA 





pathogenesis of ICA: (1) specialized ribosomes that have preferential 
translation of a certain set of transcripts which may be affected by mutations 
in RPSA or (2) RPSA that may have a yet to be discovered non-ribosomal 
function.  
RPS0 is a 252 amino acid long protein (MW ~28 kDa), It is located at 
the lower periphery of the ribosomal small subunit near the head of the 
subunit, highlighted in red in Figure 2. RPS0 is encoded by two paralogous 
genes, RPS0A (YGR214W) and RPS0B (YLR048W). A protein blast 
alignment of the two proteins in Figure 4 shows that the paralogs are 95% 
identical (240 out of 253 amino acid residues). In the results section, we use 
yeast RPS0 gene pseudo-haploinsufficiency as a model for the ICA 







Figure 23. Blast Alignment of Ribosomal Protein S0 paralog A (YGR214W) 
vs B (YLR048W). 
Protein Alignment was obtained via Blast (181). 
 
5q- Syndrome: Somatically Acquired RPS14 Gene Haploinsufficiency  
Somatically acquired 5q- syndrome, a subtype of myelodysplastic 
syndrome, is caused by haploinsufficiency for ribosomal protein S14 (RPS14) 
due to the deletion of the q arm of chromosome 5. In humans, 5q- syndrome 
presents an erythroid phenotype that is similar to DBA. The deletion of the 5q 
arm is the sole cytogenetic abnormality in 5q- patients. The disease is 
characterized by severe macrocytic anemia, elevated platelet count which are 
hypo-lobulated micro-megakaryocytes, and a predilection toward developing 
acute myeloid leukemia (AML) (200, 201). Haploinsufficiency of RPS14 via 
siRNA knockdown in CD34+ stem cells has been shown to exhibit similar 





Additionally, the forced overexpression of RPS14 in RPS14 deficient cells 
resulted in rescued erythroid phenotypes (200). Recent studies in RPS14 
haploinsufficient mammalian cells have revealed both p53 independent and 
p53 dependent tumor suppressor effects (202–204).  
RPS14 is a 137 amino acid long ribosomal protein (MW: ~15 kDA) 
located near the head of the 40S subunit of the ribosome, highlighted in green 
in Figure 2. RPS14 is encoded by two paralogous genes, RPS14A 
(YCR031C) and RPS14B (YJL191W). Figure 5 shows a protein blast 
alignment of the two RPS14 protein paralogs, revealing that the two proteins 
are 98% identical for amino acid residues and are 100% identical when one 
residue is substituted for a similar residue.  
Deletions or mutations of RPS14 are strikingly similar to mutations of 
RPS19 in DBA and RPS0 in ICA. They have been linked to inhibition of the 
late stages in the maturation of the 43S pre-ribosome particle (205–208). 
RPS14 has also been shown to engage in a “test drive” quality control 






Figure 24. Blast Alignment of Ribosomal Protein S14 paralog A 
(YCR031C) vs B (YJL191W) (YLR048W)  
Protein Alignment was obtained via Blast (181). 
 
Pseudo-haploinsufficiency in yeast as a model system for 
ribosomopathies 
Saccharomyces cerevisiae yeast was selected as a model in order to 
further understand human ribosomopathies and haploinsufficiency of 
associated ribosomal factors. Saccharomyces cerevisiae underwent a 
genome duplication event that occurred approximately a hundred millions 
years ago (210–212). While most of the duplicated genes have been lost, we 
find that several paralogous RP genes have been selected for ongoing 
preservation. The presence of paralogous genes and the relative ease of 
generating single gene paralog knockouts in the yeast genome enable a 
haploinsufficient state to exist in the pseudo-diploid yeast model system. This 
state is a condition that we refer to as pseudo-haploinsufficiency. The 
existence of paralogous RP genes that are the yeast homologs of RP genes 
associated with human RP haploinsufficient ribosomopathies enables the 





gene pseudo-haploinsufficiency and ribosomal protein heterogeneity (to an 
extent) on translational fidelity and cellular expression.  
We hypothesized that ribosomopathies caused by ribosomal protein 
haploinsufficiency cause subtle changes in translational fidelity. This affects 
the mechanism of protein synthesis, which effectively modulates gene 
expression so that it results in the phenotype exhibited by the ribosomopathy. 
In the results, we show that using RP gene pseudo-haploinsufficient yeast is 
a valid model system to investigate and monitor the effects of translational 













Scope of Work and Thesis Summary 
The project began with a question about a unique facet of 
ribosomopathies: why are they tissue specific? How can we better understand 
the nature of ribosomal dysfunction and which factors contribute to disease 
pathogenesis? At the very basic level, we understood that haploinsufficiency 
for ribosomal factors leads to ribosome dysfunction but how do we 
quantitatively assess the effects of haploinsufficiency?  The presence of 
duplicated RP genes in yeast enabled us to generate a pseudo-diploid model 
system to assess the effects that ribosomal protein haploinsufficiency have on 
ribosomal function. We were able to improve our understanding of 
haploinsufficiency as it contributes to defects in ribosomal translational fidelity 
and hence, haploinsufficiency’s effects on gene expression. This work has 
provided new insights in the nature of ribosomopathies as well as the nature 
of ribosomes.  
The scope of the research focuses on the role played by ribosomal 
dysfunction in the yeast model ribosomopathies. Research has shown that 
factors that alter the translational fidelity of the ribosome can lead to 
ribosomal dysfunction during translation, altering gene expression which can 
have deleterious downstream biological effects. The fidelity of the ribosome 
during translation is critical for regulating gene expression which is essential 
in tissue development / cellular differentiation. Recent research in our lab has 
shown a relationship between translational recoding efficiencies and gene 





ribosomal dysfunction, the primary objective of this work was to quantitatively 
measure translational recoding rates and the subsequent effects on gene 
expression. Chapter 2 will show the effects of ribosomal protein 
haploinsufficiency on translational fidelity and gene expression, the results of 
which are characteristic of specialized ribosomes. In the discussion section, 
we discuss the results and present a model for how ribosomal protein 
haploinsufficient ribosomopathies exhibit specialized ribosome behaviors that 
leads to the distinct phenotype of the ribosomopathy and how this challenges 

































Chapter 2: Results 
Ribosomal protein gene pseudo-haploinsufficiency promotes 
decreased stop codon recognition 
 
Ribosomal translational fidelity is not only measured by reading frame 
maintenance, but also by the interaction of codon:anti-codon interaction 
between the message and the tRNA that takes place in the decoding center 
of the small subunit.  There are three possible outcomes that can occur when 
the anti-codon of the tRNA interacts with the triplet nucleotide codon of the 
message RNA; a cognate pair where the triplet nucleotides of the tRNA’s anti-
codon perfectly complements the codon of the mRNA, a near-cognate pair 
where the codon:anti-codon interaction only has two of three complementary 
pairs and a non-cognate pair where the codon:anti-codon interaction do not 
share any complementary pairs. 
Ribosomal protein gene pseudo-haploinsufficient yeast were 
investigated whether pseudo-haploinsufficiency would exhibit any effect on an 
important aspect of translation; codon recognition. Stop codon recognition 
and missense incorporation, like -1 and +1 PRF, are two additional forms of 
translational recoding. Dual luciferase reporters containing these recoding 
events were assayed in yeast cells that were pseudo-haploinsufficient for 
RPS0, RPS14 or RPS19. Dual luciferase reporters contain a recoding signal 
cloned in between the Renilla and Firefly Luciferase genes. The stop codon 
recognition reporters used one of the three canonical stop codons (UAA, 





In addition to the canonical stop codons, GCN4 was selected as a proxy to 
measure the potential cumulative effect of multiple upstream ORFs prior the 
Firefly luciferase gene due to the 5’- UTR region upstream of the GCN4 gene 
containing 4 in-frame stop codons (213). The missense incorporation reporter 
assays utilized two different R218S inactivating mutations of the Firefly 
luciferase. One monitors the misreading of the non-cognate TCT mutation 
and the other monitors the misreading of a near-cognate AGC mutation.  
Overall, the results of these assays revealed decreased in stop codon 
recognition. The magnitude of this effect appeared to be isoform specific. For 
example, the loss of RPS0A promoted a greater increase in Firefly luciferase 
activity which is a byproduct of the effect of decreased stop codon 
recognition, than the loss of RPS0B for the UAG stop codon (2.58 vs 1.49 of 
fold wild-type for RPS0A∆ and RPS0B∆ respectively). The increased Firefly 
activity and isoform specific trend repeated when assaying the UGA stop 
codon (3.03 vs 1.82 fold wild-type) and the UAA stop codon (1.55 and 1.99 
fold wild-type read through rates for RPS0A∆ and RPS0B∆ respectively) 
(Figure 25A). The GCN4 reporter assay revealed that RPS0 gene pseudo-
haploinsufficiency promoted increased sequential stop codon readthrough 
(3.89 and 1.89 fold of wild-type for RPS0A∆ and RPS0B∆ respectively) 
(Figure 25A). The missense incorporation assay revealed that only the loss of 
RPS0A increased the incorporation of non-cognate (1.41 fold of wild-type) 





Stop codon recognition is inhibited by RPS14 gene pseudo-
haploinsufficiency. The translational fidelity reporter assays revealed the loss 
of either paralog of RPS14 inhibited stop codon recognition. UAA stop codon 
readthrough was found to be ~1.5 fold of wild-type, UAG stop codon 
readthrough was ~1.4 fold of wild-type and the UGA stop codon readthrough 
was 1.66 and 1.32 fold of wild-type for RPS14A∆ and RPS14B∆ respectively 
(Figure 25B). The GCN4 reporter assay exhibited the most pronounced 
effect, demonstrating that RPS14 gene pseudo-haploinsufficiency inhibited 
multiple, sequential stop codon recognition. As shown in Figure 25B, the 
GCN4 reporter assay revealed stop codon readthrough efficiencies that were 
3.60 and 5.94 fold of wild-type for RPS14A∆ and RPS14B∆ respectively. 
Missense incorporation rates was not affected by RPS14 gene pseudo-
haploinsufficiency.  
The overall decrease in stop codon recognition held for RPS19 gene 
pseudo-haploinsufficiency. RPS19 gene pseudo-haploinsufficiency 
demonstrated isoform specific effects in the three canonical stop codon 
recognition. The translational fidelity assay revealed that the RPS19 pseudo-
haploinsufficient ribosome bypassed the UAA stop codon 2.82 and 4.06 fold 
of wild-type for RPS19A∆ and RPS19B∆ respectively. The UAG stop codon 
was bypassed 2.14 and 2.37 fold of wild-type and the UGA stop codon 
bypassed 1.41 and 5.41 fold of wild-type for RPS19A∆ and RPS19B∆ 
respectively (Figure 25C). The GCN4 reporter assay revealed that RPS19 





stop codons. RPS19 pseudo-haploinsufficient ribosome, as shown in Figure 
25C, bypassed multiple sequential stop codons 5.52 and 2.39 fold of wild-
type for RPS19A∆ and RPS19B∆ respectively. The missense incorporation 
effects were demonstrated to be paralog specific. Loss of the RPS19A 
paralog stimulated non-cognate missense incorporation by 1.87 fold of wild-
type while the loss of the RPS19B paralog had no effect. In the case of near-
cognate missense incorporation, the loss of the RPS19B paralog stimulated 
incorporation by 1.83 fold of wild-type while the loss of the RPS19A paralog 



















Figure 25. Dual Luciferase reporter assays to monitor in-frame stop 
codon recognition and missense incorporation rates in Saccharomyces 
cerevisiae yeast cells.  
Stop codon read-through rates were measured in yeast strains using dual luciferase reporters 
containing in-frame stop codons; UAA, UAG, UGA. GCN4 dual luciferase reporter assay 
measured multiple in-frame upstream ORFs prior the luciferase gene (213). Error bars denote 






Ribosomal protein gene pseudo-haploinsufficient yeast cells 
demonstrated a trend of decreased stop codon recognition. RPS0 and RPS19 
gene pseudo-haploinsufficiency demonstrated paralog-specific decreased 
stop codon recognition for all canonical stop codons. All ribosomal protein 
gene pseudo-haploinsufficient yeast cells demonstrated an accumulative 
inhibitory effect when translating messages that contained multiple uORFs. 
These results suggesting that ribosomal protein composition of the ribosome 
may have a role in translational fidelity and/or codon recognition. Regardless 
of the mechanism that inhibited stop codon recognition, translational 
termination is vital to maintaining cellular homeostasis. These inhibitory 
effects demonstrated by ribosomal protein gene pseudo-haploinsufficiency 
may have deleterious downstream effects. Ultimately, these results suggest 
that decreased stop codon recognition may play an important role in the 











Ribosomal protein gene pseudo-haploinsufficient yeast cells 
exhibit idiosyncratic effects during programmed translational 
recoding events 
 
The effects of ribosomal protein gene haploinsufficiency on two 
aspects of translational recoding, -1 PRF and +1 PRF, were assayed in yeast 
cells that were pseudo-haploinsufficient for RPS0, RPS14 or RPS19. A dual 
luciferase reporter assay that contained a recoding signal cloned in between 
the Renilla and Firefly Luciferase genes. The cloned recoding signals were 
derived from viral and cellular sources. One -1 PRF signals utilized here was 
derived from the yeast L-A virus (159, 214), and other -1 PRF signals were 
derived from yeast mRNAs encoding proteins involved in telomere 
maintenance (CDC13, EST1, EST2, STN1) (100). We employed two +1 PRF 
recoding signals, one derived from the yeast OAZ1 mRNA and the other from 
the Ty1 retrotransposable element (110, 116).  
The results of these assays (Figure 26) revealed that the changes in -1 
and +1 PRF recoding efficiencies are sequence and ribosomal protein gene 
paralog specific. For example, the loss of RPS0A (i.e. in RPS0A∆ cells) 
stimulated the -1 PRF recoding when directed by the CDC13 recoding 
element to 1.73 fold of wild-type. Conversely, the loss of RPS0B inhibited the 
-1 PRF recoding when directed by the CDC13 recoding element to 0.60 fold 
of wild-type (Figure 26A). When directed by the STN1 recoding element, the 
loss of RPS0B stimulated -1 PRF to 1.83 fold of wild-type and the loss of 
RPS0A had no effect. The deletion of either RPS0 paralog had no significant 





PRF recoding elements (Figure 26A). Only the loss of RPS0A exhibited any 
change in the translational recoding efficiency of the viral LA -1 PRF recoding 
signal, demonstrated in Figure 26A by a increase in -1 PRF recoding 
efficiency to 1.37 fold of wild-type. The deletion of RPS0A increased +1 PRF 
recoding efficiency when directed by either the OAZ1 or Ty1 recoding 
elements (2.20 and 1.46 fold wild-type, respectively). However, in yeast cells 
that lacked RPS0B, only the OAZ1 recoding signal increased +1 PRF 
recoding efficiency to 1.68 fold of wild-type (Figure 26B).  
RPS14 gene pseudo-haploinsufficiency exhibited idiosyncratic effects 
in -1 and +1 PRF recoding efficiencies. RPS14 gene pseudo-
haploinsufficiency stimulated -1 PRF when directed by the EST1 recoding 
element to 3.65 and 2.21 fold of wild-type for RPS14A∆ and RPS14B∆, 
respectively (Figure 26C). The loss of RPS14A paralog inhibited -1 PRF 
recoding to 0.46 and 0.58 fold of wild-type when directed by the CDC13 and 
EST2 recoding signals, respectively. Only the loss of RPS14B demonstrated 
a reduced -1 PRF, 0.62 fold wild-type, when directed by the STN1 recoding 
signal (Figure 26D). RPS14 gene pseudo-haploinsufficiency exhibited no 
significant change in +1 PRF recoding efficiency whether directed by the 
OAZ1 or the Ty1 recoding element (Figure 26D).  
RPS19 gene pseudo-haploinsufficiency revealed that the effects of 
programmed frameshift recoding to be paralog specific. RPS19 gene pseudo-
haploinsufficiency increased -1 PRF recoding efficiencies when directed by 





and RPS19B∆, respectively (Figure 26E). The loss of RPS19B increased -1 
PRF recoding efficiencies to 1.61 and 1.57 fold of wild type for the LA and 
EST1 recoding signals, respectively (Figure 26E). RPS19 gene pseudo-
haploinsufficiency stimulated +1 PRF recoding when directed by the Ty1 
recoding signal to 1.35 and 1.76 fold of wild-type for RPS19A∆ and 
RPS19B∆, respectively (Figure 26F). +1 PRF rates when directed by the 
OAZ1 recoding element was shown to be unaffected by RPS19 gene pseudo-




















Figure 26. Dual Luciferase reporter assays to monitor -1 PRF and +1 
PRF in single isoform knockout of RPS0, RPS14 and RPS19 
Saccharomyces cerevisiae yeast cells. 
-1 PRF was monitored using dual luciferase reporters (78) in isogenic Saccharomyces 
cerevisiae cells expressing the isogenic A gene deletion or the isogenic gene deletion. All 
assays were repeated to generate statistically meaningful results. +1 PRF rates were 
measured in yeast strains using frameshift signal derived from yeast Ty1 retrotransposable 
element and OAZ1. Error bars denote standard error. All results are expressed as fold WT. *P 






Ribosomal protein gene pseudo-haploinsufficiency exhibited 
idiosyncratic results when quantifying its effects on programmed 
frameshifting. The lack of any discernable trend suggested that changes in 
recoding efficiencies may be an effect of unique ribosomal composition 
interacting with specific recoding signals. The results did not offer any 
discernable mechanism but did suggest that ribosomal protein pseudo-
haploinsufficient ribosomes may have downstream implications. The 
downstream effects would be due to the idiosyncratic responses to 
programmed frameshifting recoding signals which may alter gene expression. 
Ribosomal protein gene pseudo-haploinsufficent yeast 
exhibit idiosyncratic effects in mRNA abundances of 
sequences that contain recoding elements 
 
Recent studies revealed an inverse correlation between -1 PRF and 
steady state abundances of yeast telomere maintenance genes (100). A -1 
PRF recoding event will direct the ribosome into an alternate reading frame 
and encounter a premature termination codon, triggering the nonsense 
mediated mRNA decay pathway (NMD). The nonsense mediated mRNA 
decay pathway functions to regulate the transcriptome by quickly degrading 
aberrant messages. The efficiency of the NMD surveillance pathway is highly 
contingent on translational termination or in other words, stop codon 
recognition (215, 216).  The decreased stop codon results led to the 
hypothesis that the steady state mRNA abundances in ribosomal protein 





abundance through Non-Stop Decay. This hypothesis would mean that this 
decreased stop codon recognition reduces the efficiency of NMD’s role in 
regulating mRNA abundances.  
Yeast telomere maintenance genes CDC13, EST1, EST1 and STN1 all 
contain bona fide -1 PRF signals. Recent studies of steady state mRNA 
abundances of these genes revealed a stochastic correlation to maintaining 
telomere length (100), linking recoding rates and biological function. 
Endogenous EST3, also a component of the telomere holoenzyme, and 
OAZ1, a ornithine decarboxylase antizyme, were probed to quantify the 
effects of ribosomal protein gene pseudo-haploinsufficiency on steady state 
mRNA abundances of messages containing +1 PRF recoding elements (112, 
114, 116). The steady state mRNA abundances were then determined by 
qRT-PCR with U3 snoRNA as the loading control. 
RPS0 gene pseudo-haploinsufficiency generally promoted decreased 
steady state mRNA abundances for messages that contained frameshift 
recoding signals. Quantitative Real Time PCR assays revealed that the loss 
of either paralog of RPS0 decreased mRNA abundance of messages that 
contained a -1 PRF recoding element to approximately half of wild-type. The 
mRNA abundance of EST1, EST2, and STN1 were decreased to 0.46, 0.48, 
0.36 fold of wildtype for RPS0∆ yeast cells. In RPS0B∆ yeast cells, the mRNA 
abundance for EST1, EST2, and STN1 were decreased to 0.43, 0.47, 0.39 
fold of wildtype, respectively. The exception to this trend was CDC13, a yeast 





which exhibited an increase in mRNA abundance to 2.45 and 2.31 fold of 
wild-type for RPS0A∆ and RPS0B∆ respectively (Figure 27A). RPS0 gene 
pseudo-haploinsufficiency decreased the steady state mRNA abundances of 
messages containing +1 PRF recoding elements to less than half of wild-type 
(Figure 27A). RPS0A∆ yeast cells exhibited a decreased mRNA abundance 
that were 0.22 and 0.48 fold of wildtype for EST3 and OAZ1 respectively. The 
loss of RPS0B∆ decreased mRNA abundance of EST3 and OAZ1 to 0.19 and 
0.54 fold of wildtype, respectively. 
RPS14 gene pseudo-haploinsufficiency demonstrated sequence and 
paralog specific effects in mRNA abundances of messages containing any 
frameshift-type recoding element. The most noticeable effect was the change 
in the steady state mRNA abundance of CDC13. RPS14 gene pseudo-
haploinsufficiency increased CDC13 mRNA abundance to 3.8 and 5.6 fold of 
wild-type for RPS14A∆ and RPS14B∆, respectively (Figure 27B). Of the 
remaining -1 PRF probes, only STN1 exhibited significant decreased mRNA 
abundances (0.58 and 0.72 fold of wild-type for RPS14A∆ and RPS14B∆ 
respectively). Of the two +1 PRF probes, RPS14 gene pseudo-
haploinsufficiency demonstrated a significantly decreased mRNA abundance 
for the EST3 message, which was decreased to 0.34 and 0.43 fold of wild-
type for RPS14A∆ and RPS14B∆ respectively. However, or the OAZ1 +1 PRF 
probe, only the loss of RPS14A resulted in a decrease in mRNA abundance 





RPS19 gene pseudo-haploinsufficiency revealed a global decrease in 
steady state mRNA abundances. The loss of either RPS19 paralog 
decreased the steady state mRNA abundance to less than half of the wild-
type control (Figure 27C). The mRNA abundances of CDC13, EST1, EST2 
and STN1 were decreased to 0.40, 0.62, 0.51 and 0.48 fold of wild-type, 
respectively, for RPS19A∆ yeast cells. RPS19B∆ yeast cells exhibited a 
decrease in mRNA abundance to 0.16, 0.22, 0.17 and 0.20 fold of wild-type 
for CDC13, EST1, EST2 and STN1, respectively (Figure 27C). Messages that 
contained +1 PRF recoding signals demonstrated a global decrease of mRNA 
abundance in RPS19 gene pseudo-haploinsufficient yeast cells. The loss of 
RPS19A decreased the mRNA abundance of EST3 and OAZ1 to 0.74 and 
0.41 fold of wildtype, respectively. The loss of RPS19B decreased the mRNA 










Figure 27. qualitative Real Time Polymerase Chain Reaction (qRT-PCR) 
to measure steady state mRNA abundances of yeast telomere length 
messages and messages containing translational recoding signals 
Steady-state endogenous abundances of CDC13, EST1, EST2, STN1, EST3 and OAZ1 
mRNAs were monitored using quantitative RT-PCR in yeast strains. Error bars denote standard 







 The results did not support the original hypothesis. RPS0 and RPS14 
gene pseudo-haploinsufficiency exhibited similar but idiosyncratic mRNA 
abundances while RPS19 gene pseudo-haploinsufficient yeast demonstrated 
a global decrease in mRNA abundance of messages that contain frameshift 
recoding signals. The absence of any discernable trend of frameshifting rates 
in Figure 26 and in conjunction with inhibited stop codon recognition rates as 
shown in Figure 25, lead to the question whether the efficiencies of mRNA 
decay mechanisms were altered by ribosomal protein gene pseudo-
haploinsufficiency. 
Ribosomal protein gene pseudo-haploinsufficiency decreases 
the mRNA abundances of sequences that are substrates for 
Nonsense Mediated Decay (NMD) 
Saccharomyces cerevisiae yeast cells that are ribosomal protein gene 
pseudo-haploinsufficient do not follow the inverse correlation between -1 PRF 
efficiencies and mRNA abundance. The increased CDC13 mRNA abundance 
found in RPS0 and RPS14 gene pseudo-haploinsufficient yeast cells (Figure 
27A and B) led to the question whether the Nonsense Mediated Decay 
pathway was affected. However, as the dual luciferase reporter assays 
revealed an overall decrease in stop codon recognition and the fact that the 
efficiency of the NMD surveillance pathway is highly contingent on 
translational termination or in other words, stop codon recognition (215, 216). 
We developed a hypothesis that the inhibited stop codon recognition directed 
the ribosome to bypass the premature termination codons, continue 





ribosome at the polyA tail of the message would then elicit mRNA 
degradation via the NSD pathway instead of the NMD pathway. RPS19 gene 
pseudo-haploinsufficiency qRT-PCR results support this hypothesis. 
Messages that were natural targets for decay via NMD were selected 
to test whether the NMD surveillance pathway was inhibited by ribosomal 
protein gene pseudo-haploinsufficiency. Messenger RNAs that contain 
uORFs are natural substrates for NMD. GCN4 (a transcriptional activator 
(213)), CPA1 (a component of the carbamoyl phosphatase synthetase (217)) 
and NMD4 (a component of the NMD mechanism (218)) are known yeast 
NMD substrates due to their mRNAs containing uORFs which triggers the 
NMD surveillance pathway and regulates their mRNA abundances (219–222).  
RPS0 gene pseudo-haploinsufficiency conferred a global decrease in 
mRNA abundances of messages that containing uORFs and are substrates 
for NMD. Multiple uORFs destabilize the GCN4 mRNA and decreased the 
steady state mRNA abundance to ~0.23 fold relative to wild-type.  RPS0 gene 
pseudo-haploinsufficiency decreased the steady state mRNA abundances of 
messages containing a single uORF; CPA1 mRNA abundance was 
decreased to 0.31 and 0.43 fold of wild-type for RPS0A∆ and RPS0B∆, 
respectively. The mRNA abundance of NMD4 was decreased to 0.30 and 
0.35 fold of wild-type for RPS0A∆ and RPS0B∆, respectively (Figure 28A).  
RPS14 gene pseudo-haploinsufficient yeast cells exhibited similar 





haploinsufficient yeast cells. The presence of multiple uORFs decreased the 
GCN4 message to 0.32 and 0.38 fold of wild-type for RPS14A∆ and 
RPS14B∆, respectively (Figure 28B).  Messages that contain single uORFs 
also exhibited decreased mRNA abundances; CPA1 mRNA abundance was 
decreased to 0.48 fold of wild-type for RPS14A∆ while RPS14B∆ exhibited a 
0.87 fold of wildtype decrease. RPS14 gene pseudo-haploinsufficiency 
decreased the mRNA abundance of NMD4 to 0.46 and 0.57 fold of wild-type 
for RPS14A∆ and RPS14B∆, respectively (Figure 28B).   
RPS19 gene pseudo-haploinsufficient yeast cells demonstrated a 
global decrease in mRNA abundance that was paralog specific. The loss of 
the RPS19B paralog resulted in an mRNA abundance that was half of that 
found in RPS19A∆ yeast cells (Figure 28C). The GCN4 message was 
decreased to 0.60 and 0.27 fold of wild-type for RPS19A∆ and RPS19B∆, 
respectively (Figure 28C).  Messages that contained single uORF exhibited 
similar mRNA abundance decreases in RPS19 gene pseudo-haploinsufficient 
yeast. The mRNA abundance for CPA1 was decreased to 0.58 and 0.16 fold 
of wild-type for RPS19A∆ and RPS19B∆, respectively. NMD4 mRNA 
abundance was decreased to 0.49 and 0.19 fold of wild-type for RPS19A∆ 









Figure 28. qualitative Real Time Polymerase Chain Reaction (qRT-PCR) 
to measure steady state mRNA abundances of substrates for NMD  
Steady-state mRNA abundances of the endogenous messages containing elements that 
trigger the NMD surveillance pathway; GCN4, CPA1, and NMD4 were monitored using 
quantitative RT-PCR in yeast strains. Error bars denote standard error. *P < 0.05, **P < 0.01. 





All ribosomal protein gene pseudo-haploinsufficient yeast revealed a 
global decrease in mRNA abundance of messages that were substrates for 
NMD. Regardless of which paralog is deleted in RPS0 and RPS14 gene 
pseudo-haploinsufficient yeast cells, both exhibited similar decreases in 
mRNA abundances of messages that were substrates for NMD. Only RPS19 
gene pseudo-haploinsufficient yeast exhibited paralog-specific decreases in 
these messages. These results are suggestive of either increased global 
mRNA decay activity or an increase in mRNA decay of specific messages, 
i.e. those that contain elements that are substrates for either NMD, NSD or 
NGD. 
Ribosomal protein gene pseudo-haploinsufficiency confers 
sequence specific effects to mRNA abundances of 
housekeeping messages 
The messages examined thus far all have elements that destabilize 
their mRNAs. Subsequently, the question became whether ribosomal protein 
pseudo-haploinsufficiency would affect the steady state mRNA abundances 
of messages that are inherently stable, i.e. transcripts that do not contain 
elements that direct the message to one of the three mRNA surveillance 
pathways. New targets were selected on the basis of their stability and 
“housekeeping” roles in the yeast cell; ACT1 encodes for actin, an essential 
cytoskeletal element that is used in many cellular processes (223). BRR6 
encodes for an essential nuclear envelope integral membrane protein (224). 





phosphoglycerate kinase, an enzyme used for glycolysis (226). TUB1 
encodes for alpha-tubulin which polymerizes to form microtubules (227). 
RPS0 gene pseudo-haploinsufficiency continued to demonstrate 
message specific effects in mRNA abundances of messages lacking 
elements that trigger mRNA decay pathways. The mRNA abundance of ACT1 
was decreased to 0.57 and 0.41 fold of wild-type for RPS0A∆ and RPS0B∆, 
respectively (Figure 29A).  RPS0 gene pseudo-haploinsufficiency decreased 
the mRNA abundance of BRR6 to 0.50 fold of wild-type for both RPS0A∆ and 
RPS0B∆. HOM3 was decreased to 0.43 and 0.67 fold of wild-type for 
RPS0A∆ and RPS0B∆, respectively. The mRNA abundance of PGK1, a 
highly stable message, was decreased to 0.22 and 0.17 fold of wild-type for 
RPS0A∆ and RPS0B∆, respectively. Unlike the other messages, RPS0 gene 
pseudo-haploinsufficiency increased the mRNA abundances of TUB1 to 1.34 
fold of wild-type for RPS0A∆ and exhibited no mRNA abundance change in 
RPS0B∆ yeast cells. 
RPS14 gene pseudo-haploinsufficient yeast demonstrated sequence 
specific mRNA abundance effects. RPS0A∆ yeast did not cause any change 
in ACT1 mRNA abundance, but the loss of RPS0B decreased ACT1 mRNA 
abundance to 0.72 fold of wild-type (Figure 29B). The mRNA abundance of 
BRR6 was reduced to 0.60 and 0.70 fold of wild-type for RPS14A∆ and 
RPS14B∆, respectively. RPS14 gene pseudo-haploinsufficiency exhibited 
paralog specific effects on the mRNA abundances for HOM3; the loss of the 





while the loss of RPS14B increased the mRNA abundance to 1.44 fold of 
wild-type (Figure 29B). The mRNA abundance of the stable PGK1 message 
was decreased to 0.48 and 0.56 fold of wild-type for RPS14A∆ and 
RPS14B∆, respectively (Figure 29B). Unlike the other messages, RPS14 
gene pseudo-haploinsufficiency increased the mRNA abundance of TUB1 to 
2.64 and 3.18 fold of wildtype for RPS14A∆ and RPS14B∆, respectively 
(Figure 29B). 
RPS19 gene pseudo-haploinsufficient continued to demonstrate a 
decreased steady-state mRNA abundances for all messages. RPS19 gene 
pseudo-haploinsufficiency decreased the mRNA abundances for all 
housekeeping messages (Figure 29C). The mRNA abundance of ACT1 was 
reduced to 0.50 and 0.19 fold wild-type for RPS19A∆ and RPS19B∆, 
respectively. The mRNA abundance of BRR6 decreased to 0.58 and 0.27 fold 
of wild-type for RPS19A∆ and RPS19B∆, respectively. The mRNA abundance 
of HOM3 decreased to 0.53 and 0.22 fold of wild-type for RPS19A∆ and 
RPS19B∆, respectively. The stable PGK1 exhibited a decrease in mRNA 
abundance to 0.37 and 0.26 fold of wild-type for RPS19A∆ and RPS19B∆, 
respectively. TUB1 mRNA abundances were reduced to 0.49 and 0.23 fold of 











Figure 29. qualitative Real Time Polymerase Chain Reaction (qRT-PCR) 
to measure steady state mRNA abundances of housekeeping messages 
that are substrates for NMD and stable messages. 
Steady-state mRNA abundances of endogenous ACT1, BRR6, HOM3, PGK1, and TUB1 were 
monitored using quantitative RT-PCR in yeast strains. Error bars denote standard error. *P < 





Ribosomal protein gene pseudo-haploinsufficiency decreases 
total mRNA abundances for sequences that code for 
ribosomal proteins 
Ribosomal protein pseudo-haploinsufficient yeast demonstrate a 
general trend of decreased mRNA abundances globally. Only RPS19 gene 
pseudo-haploinsufficiency exhibits a total global decrease in mRNA 
abundance of all messages probed via qRT-PCR. RPS0 and RPS14 gene 
pseudo-haploinsufficient yeast have exhibited increased mRNA abundances 
in specific messages. Expression of ribosomal proteins are coordinated in a 
stochastic ratio necessary for ribosomal assembly (19). This lead to the 
question whether RP pseudo-haploinsufficiency down regulated all messages 
or if pseudo-haploinsufficiency confers unique coordinated expression of 
proteins.  Probes were designed to quantify total mRNA abundance of each 
of the three selected ribosomal proteins, while not differentiating between 
paralogs. The isogenic wild-type yeast cell was determined the norm control 
and the U3 snoRNA as the loading control. Each yeast strain was quantified 
for the total mRNA abundance for RPS0, RPS14 and RPS19 to determine if 
the change in mRNA abundance would consistent between paralogs and 
revealed demonstrated a coordinated effect.  
RPS0 gene pseudo-haploinsufficient yeast cells revealed a similar 
decrease in mRNA abundance in all probed RP mRNAs. The mRNA 
abundance for RPS0 was decreased to 0.20 and 0.15 fold of wild-type for 
RPS0A∆ and RPS0B∆, respectively. The mRNA abundance for RPS14 in 





fold of wild-type. The mRNA abundance of RPS19 in RPS0 gene pseudo-
haploinsufficient yeast cells was decreased to 0.26 and 0.21 fold of wild-type 
(Figure 30A). 
RPS14 gene pseudo-haploinsufficient yeast cells continued to 
demonstrate similar global decreased RP mRNA abundances. The mRNA 
abundance for RPS0 was decreased to 0.46 and 1.52 fold of wild-type for 
RPS14A∆ and RPS14B∆, respectively. The mRNA abundance for RPS14 
was found to be 0.22 and 0.36 fold of wild-type, and similar to the mRNA 
abundance of RPS0 and RPS14, RPS19 demonstrated a decrease to 0.36 
and 0.35 fold of wild-type (Figure 30B). 
Like RPS0 and RPS14 gene pseudo-haploinsufficiency, RPS19 gene 
pseudo-haploinsufficient yeast cells demonstrated global decreased RP 
mRNA abundances. However, the extent of the decrease was paralog 
specific. Similar to previous qRT-PCR data, RPS19 gene pseudo-
haploinsufficient yeast cells continued to demonstrate a pattern where the 
loss of RPS19B resulted in a quantified mRNA abundance that would be 
roughly half to the mRNA abundance of the same message in RPS19A gene 
pseudo-haploinsufficient yeast cells. The mRNA abundance for RPS0 was 
found to be 0.82 and 0.42 fold of wild-type for RPS19A∆ and RPS19B∆, 
respectively. The mRNA abundance of RPS14 decreased to 0.75 and 0.37 
fold of wild-type for RPS19A∆ and RPS19B∆, respectively. However, the 
mRNA abundance for RPS19 demonstrated a decrease that was 0.73 and 








Figure 30. qualitative Real Time Polymerase Chain Reaction (qRT-PCR) 
to measure the global steady state mRNA abundances of ribosomal 
protein messages 
Steady-state mRNA abundances of endogenous RPS0, RPS14 and RPS19 were monitored 
using quantitative RT-PCR in yeast strains. Error bars denote standard error. *P < 0.05, **P < 





All ribosomal protein gene pseudo-haploinsufficient yeast cells 
demonstrated a decrease in global RP mRNA abundances. The results 
showed that, except for RPS19B∆ yeast, reduced ribosomal protein 
expression conferred a coordinated expression of other ribosomal proteins to 
similar mRNA abundances. This suggests that, at least in the yeast model, 
ribosomopathies may have a selective and coordinated expression of 
messages.  
Ribosomal protein gene pseudo-haploinsufficient yeast cells 
present mRNA abundances characteristic of cellular stress 
and increased ribosomal turnover  
The messages examined thus far all have elements that destabilize 
their mRNAs. Subsequently, the question became whether ribosomal protein 
pseudo-haploinsufficiency would affect the steady state mRNA abundances 
of messages that are inherently stable, i.e. transcripts that do not contain 
elements that direct the message to one of the three mRNA surveillance 
pathways. New targets were selected on the basis of being affected by 
cellular stress, high ribosomal turnover and increased ribosomal biogenesis. 
ADE4 encodes for a protein that catalyzes first step of the 'de novo' purine 
nucleotide biosynthetic pathway (228) and would be upregulated in scenarios 
with high ribosomal turnover and increased ribosomal biogenesis. CCR4 
encodes for a dominant polydeadenylase, an essential component for mRNA 
degradation (229). HAC1 encodes for a transcriptional activator that is 
involved in the unfolded protein response where ribosomes that are stalled in 





LUC7 encodes for an essential protein associated with the U1 snRNP 
complex (231, 232), and PRP8 encodes for an component of U4/U6-U5 
snRNP complex (233–235).  
RPS0 gene pseudo-haploinsufficiency continued to have message 
specific effects on mRNA abundances. RPS0 gene pseudo-haploinsufficiency 
increased mRNA abundances for ADE4 to 3.69 and 2.38 fold of wild-type for 
RPS0A∆ and RPS0B∆ respectively. The mRNA abundance of CCR4 was 
increased to 4.84 and 4.19 fold wild-type for RPS0A∆ and RPS0B∆ 
respectively (Figure 31A). Only RPS0B∆ had a significant increase in the 
mRNA abundance of HAC1, 1.44 fold of wild-type, while RPS14A∆ exhibited 
an increase of 1.11 fold of wild-type. RPS0A∆ yeast cells revealed no change 
in mRNA abundance of LUC7 while RPS0B∆ yeast decreased the mRNA 
abundance of LUC7 to 0.83 fold of wild-type (Figure 31A). RPS0 gene 
pseudo-haploinsufficiency increased the mRNA abundance of PRP8 to 4.15 
and 3.69 fold of wild-type for RPS0A∆ and RPS0B∆ respectively.  
RPS14 gene pseudo-haploinsufficient yeast demonstrated an overall 
increase in mRNA abundance. The extent of the increase in mRNA 
abundance were sequence specific. The mRNA abundance of ADE4 was 
increased to 7.79 and 6.64 fold of wild-type for RPS14A∆ and RPS14B∆, 
respectively (Figure 31B). RPS14 gene pseudo-haploinsufficiency increased 
the mRNA abundance of CCR4 to 5.47 and 6.49 fold of wild-type for 
RPS14A∆ and RPS14B∆, respectively. The mRNA abundance of HAC1 was 





respectively. LUC7 mRNA abundances were increased to 1.22 and 1.57 fold 
of wild-type for RPS14A∆ and RPS14B∆, respectively. RPS14 gene pseudo-
haploinsufficient yeast demonstrated a large increase in the mRNA 
abundance of PRP8, 7.32 and 8.02 fold of wild-type RPS14A∆ and 
RPS14B∆, respectively. 
RPS19 gene pseudo-haploinsufficient yeast cells continued to 
demonstrate a global decrease in mRNA abundances for all messages. The 
extent of this decrease in mRNA abundance also continued to be paralog-
specific. RPS19 gene pseudo-haploinsufficiency decreased the mRNA 
abundances of ADE4 to 0.50 and 0.19 fold of wild-type for RPS19A∆ and 
RPS19B∆, respectively (Figure 31C). The mRNA abundance of CCR4 was 
decreased to 0.50 and 0.12 fold of wild-type for RPS19A∆ and RPS19B∆, 
respectively. HAC1 mRNA abundances were reduced to 0.33 and 0.12 fold of 
wild-type in RPS19A∆ and RPS19B∆ yeast cells, respectively. The mRNA 
abundances of LUC7 decreased to 0.41 and 0.17 fold of wild-type for 
RPS19A∆ and RPS19B∆, respectively. PRP8 mRNA abundances were 
decreased to 0.26 and 0.13 fold of wild-type in RPS19A∆ and RPS19B∆ 








Figure 31. qualitative Real Time Polymerase Chain Reaction (qRT-PCR) 
to measure steady state mRNA abundances of messages associated to 
cellular stress and ribosomal turnover 
Steady-state mRNA abundances of endogenous ADE4, CCR4, HAC1, LUC7, PRP8 were 
monitored using quantitative RT-PCR in yeast strains. Error bars denote standard error. *P < 





RPS0 and RPS14 gene pseudo-haploinsufficient yeast demonstrated 
strikingly similar effects on mRNA abundances. RPS0 and RPS14 gene 
pseudo-haploinsufficiency demonstrated an upregulation of messages 
associated to cellular stress and ribosomal turnover. These two RP gene 
pseudo-haploinsufficient yeast strains increased the mRNA abundance of 
ADE4, CCR4 and PRP8. The qRT-PCR studies revealed that CCR4 has an 
at least 4 fold increase in mRNA abundance relative to WT, this upregulation 
may be due to an elicited response to the need for an increased degradation 
of mRNAs. These messages could be upregulated during cellular stress 
conditions; where ribosomal turnover rates are high and messages are 
degraded rapidly. This would promote the need for increased transcription, 
i.e. increased adenine synthesis (ADE4), and increased splicing of messages 
(LUC7 and PRP8). The mRNA abundance of HAC1 was increased in RPS0 
or RPS14 gene pseudo-haploinsufficient yeast. HAC1 is used as a proxy for 
NSD and the slight increase in mRNA abundance of this message relative to 
wild-type suggests that this upregulation is due to increased unfolded protein 
response. These results suggests that RPS0 or RPS14 pseudo-
haploinsufficient ribosomes cannot terminate properly and the ribosome, 







Chapter 3: Discussion/Conclusions and Future 
Directions 
 
In the central dogma of molecular biology, translation is a late process 
that occurs between mRNA synthesis and protein degradation. Translation is 
a complex process which involves the rapid and high-fidelity interactions of 
the mRNA, the ribosome and complementary GTPases that deliver amino-
acylated tRNAs to the ribosome and translocation along the message. 
Faithful translation of the mRNA ensures the proper propagation of genetic 
information essential to cellular homeostasis. Translation of genetic 
information can be influenced by rRNA post-transcriptional modifications that 
induce translational recoding events which modulates cellular gene 
expression (113, 155, 236). The translational apparatus has a system of 
checks and balances for regulating cellular homeostasis. The translational 
machinery has evolved mechanisms to ensure degradation of messages that 
harbor errors that may produce deleterious effects. In investigating 
translational recoding, e.g. -1 PRF, it was discovered these recoding events 
can be used as a means to regulate mRNA abundances and gene expression 
by directing the message to a nonsense codon that elicits the nonsense 
mediated decay mechanism to degrade the message (98).  
A new class of diseases is now gaining attention. Ribosomopathies are 
characterized by congenital or somatically acquired mutations of a ribosomal 
factor that leads to ribosomal dysfunction. Studies show that altering the 





recoding efficiencies that in turn dysregulates gene expression (100, 156, 
157, 159). Warner’s work shows that the stoichiometric relationship between 
the rRNAs and ribosomal proteins is regulated by the cell to promote their 
equimolar assembly into ribosomes (19). According to this study, insufficiency 
or excess of any component may result in aberrant ribosomal protein 
processing and the disruption of ribosome production. However, we argue in 
this thesis that the etiology of ribosomopathies, at least in those that are 
caused by ribosomal protein gene haploinsufficiency, are attributed to altered 
translational fidelity, and are not wholly attributed to the diminished quantity of 
mature ribosomes.  
The yeast Saccharomyces cerevisiae is a robust model system to 
investigate the etiology of ribosomopathies. The naturally duplicated 
ribosomal protein genes of haploid yeast cells provide us with the opportunity 
to use a pseudo-diploid model. One of the many defining characteristics that 
make yeast a model system is the ability to genetically manipulate the 
genome, generating yeast strains that contain single isoform knock out of 
ribosomal protein genes. This provided us a platform to investigate the effects 
of pseudo-haploinsufficiency of ribosomal proteins during translation.  
Yeast ribosomal protein pseudo-haploinsufficient studies reveal 
defects in the translational machinery. Monitoring the translational fidelity of 
the ribosome via measuring translational recoding efficiencies, -1 PRF and +1 
PRF efficiencies revealed isoform and sequence specific effects. However the 





exhibited increased stop codon readthrough. The largest effect of inhibited 
stop-codon recognition is evident during the GCN4 reporter assay which 
contains multiple uORFs. These results suggests an additive effect in stop 
codon readthrough efficiency of pseudo-haploinsufficient ribosomes. If the 
ribosome is directed to a premature termination codon, NMD–dependent 
mRNA degradation  is contingent on stop codon recognition (215, 216).  
Probing the steady-state abundances of messages containing frameshift 
recoding elements (-1 and +1 PRF signals) revealed that pseudo-
haploinsufficiency for RPS19 is unique in expressing a global decrease for all 
mRNA sequences, the extent of which is paralog-specific. Pseudo-
haploinsufficiency for RPS0 and RPS14 exhibits a general decrease in mRNA 
abundance with the exception of a single mRNA, CDC13. The combination of 
the results from the dual luciferase reporter assays and the qRT-PCR assays, 
led us to the hypothesis that increased rates of stop codon readthrough 
increases the fraction of ribosomes that read through bona fide termination 
codons, leading to increased rates of NSD on all mRNAs. To test that 
hypothesis, we probed messages that contained uORfs that made the 
messages into substrates for NMD (GCN4, CPA1 and NMD4). We also 
investigated messages that were essential for cellular function but lacked 
elements that would make them targets for degradation (ACT1, BRR6, 
HOM3, PGK1, and TUB1). The results reveal that ribosomal protein pseudo-
haploinsufficiency confers sequence and paralog specific effects on mRNA 





property that is predicted to be associated with ‘specialized’ ribosomes. In 
support of this, preliminary results suggest that the translational fidelity 
defects exhibited by the ribosomal protein pseudo-haploinsufficiency are at 
least partially reproducible in the mammalian system. Specifically, our 
collaborator was able to generate a single copy knockout of RPS19 in HEK 
cells by using the CRISPR-Cas9 system. Mammalian cells containing a single 
copy of RPS19 exhibited increased stop codon readthrough rates. 
The nature of ribosomopathies and the observations in pseudo-
haploinsufficient yeast cells challenges our current understanding of the 
ribosome. Historically, the ribosome has been thought to be monolithic in 
nature, a singular and precise nanomachine capable of performing all 
translational functions perfectly. The observation that single ribosomal protein 
gene deletions in yeast exhibits idiosyncratic effects suggests that this is not 
necessarily the case. This indicates that each RP gene paralog represents a 
potential source of heterogeneity. It also forces the question, which is more 
plausible: that nature would select for n unique and functionally maximized 
machine with the ability to translate infinite mRNAs in response to an infinite 
number of stimuli? Or a system with the capacity to generate an infinite set of 
variations of the same machine, each endowed with its own idiosyncratic 
properties? Consider that within this heterogeneous population of ribosomes, 
there exists a minimum of 278 variations, as eukaryotic genomes contain two 
copies of 78 protein genes, and each of the 4 rRNAs contain 212 potentially 





number of different ribosomal compositions and each with its own 
idiosyncratic property. Supposing that it is the latter, there are three 
implications. First, ribosomal factor haploinsufficiency leads to the unique 
functional loss for that the ribosomal factor would have otherwise served. 
Second, the subset of ribosomes that are missing the ribosomal factor or 
possesses a mutated form of it are translationally dysfunctional and the 
altered translational fidelity of these ribosomes will disrupt normal decay 
mechanisms that will result in differential gene expression. Finally, the 
differential gene expression begins a domino effect in the cell which ultimately 
leads to the clinical presentation of the ribosomopathy associated to the initial 
ribosomal factor gene. Hematopoiesis and neuronal tissue differentiation 
relies on gene expression to regulate tissue proliferation and differentiation, 
processes that are wholly contingent on ribosomal translational fidelity and 
mRNA decay mechanisms (153, 237). Our argument posits that specific 
tissues require ribosomes capable of specific translational patterns in order to 
regulate gene expression to promote cellular differentiation. When genes that 
encode ribosomal factors capable of regulating gene expression are missing 
or mutated, these tissues cannot sufficiently differentiate or develop into adult 
cells. As applied to more complex organisms, the hypothesis that differential 
ribosomal composition is required to promote tissue specific cell 






Environmental conditions can exert influence on cellular gene 
expression. Ribosomal assembly is an energetically expensive process under 
normal conditions and can be influenced by cellular stress conditions as a 
response to maintain cellular homeostasis. In the monolithic ribosomal model, 
in order to respond to changes in environmental factors, another layer of 
interaction and complexity is required to force changes in the ribosome. This 
additional step would need to be able to provide for a specific translational 
pattern in order to result in a specific differential gene expression that would 
accommodate the cell’s needs in response to the stressor.  In contrast, a 
heterogeneous population of ribosomes model presents an alternate solution 
for regulating translation patterns without (or bypassing) the extra layer of 
complexity. The heterogeneous ribosome model provides a reductionist 
mechanism to fit (accommodate) the cell’s translational needs in order to 
maintain/ensure essential cellular functions to promote optimal adaptability in 
response to environmental stimuli. The heterogeneous ribosome model also 
provides an additional mechanism for epigenetics, where external factors may 
influence gene expression, for “increased genetic adaptability” beyond the 
rate of natural selection/evolution, promoting beneficial inheritable genetic 
traits. Ribosomal protein gene haploinsufficiency has been shown to induce 
the p53 pathway, a response reserved for ribosomal and cellular stress. 
Diamond Blackfan Anemia patients with mutations of RPS19  and 5q- 
syndrome patients express increased activation of the p53 pathway in 





The idea of a heterogeneous population of ribosomes is consistent 
with the selective translating behavior of ‘specialized’ ribosomes. The 
heterogeneous ribosome model is similar to the viral quasispecies model, 
proposed by Eigen and Schuster (239). Eigen and Schuster determined that 
in an environment of high mutation rate and thermodynamic conditions far 
from equilibrium, the original self-replicating entity reaches a maximum 
reproductive fitness and this self-replicating entity was represented as a “clan” 
and not as a single molecule (239). This “clan” would consist of a distribution 
heterogeneous population of viruses and this distribution was then referred as 
“quasispecies”. This theory links Darwinian evolution and chemical 
thermodynamics and kinetics. In the context of chemical thermodynamics and 
kinetics, viral genomes that are thermodynamically cheaper would always 
exist and accumulate in greater number relative to those that are more 
thermodynamically expensive. This creates a “thermodynamic” selective 
pressure. This is akin to Darwinian selective pressure that, in a non-
equilibrium scenario involving self-reproduction, mutation and degradation of 
the viral genome, will select certain genotypes and regulate the abundance of 
viral particles. Only viral variants nearest to the optimal fitness are capable of 
surviving this selective process. According to the quasispecies model, 
selection is based on the competition between phenotypes (in response or 
adaptation to environmental conditions) or the ability to produce progenies.  
We developed a new model for ribosomes, the ribosomal quasispecies 





heterogeneous variants. Cellular chemical thermodynamics and kinetics 
dictates the presence of a habitable zone. There exists a need for a minimum 
and maximum in the accuracy and speed of translation, e.g. KD of tRNAs an 
Kcat of protein formation, to maintain cellular homeostasis (Figure 32). A even 
distribution of ribosomes that exists within these boundaries serve as a 
buffering zone; a system of checks and balances where each ribosomal 
variant will translate each message uniquely in respect to elements that can 
destabilize the message. Some ribosomes will be redirected by the recoding 
element and lead to a premature termination codon and initiate the NMD-
dependent pathway. Other ribosomes may not be redirected by the same 
recoding element and the message will remain intact for another round of 
translation. This allows the transcriptome to maintain homeostasis, to exist 
between a minimum for cellular survival and a maximum before deleterious 
effects occur. The ribosomal assembly is dictated by thermodynamic cost. 
Thus in non-equilibrium scenarios, e.g. development of precursor red blood 
cells into adult red blood cells or in cell stress conditions, the distribution of 
ribosomal variants shifts to those that are thermodynamically essential to 
maintain cellular homeostasis (Figure 32). Ribosomopathies by 
haploinsufficiency of ribosomal protein eliminates this subset of ribosomal 
variant and forces the distribution of ribosomes to beyond the boundaries of 
the habitable zone (Figure 32). Those that exist within the habitable zone 
exhibit translational patterns unique to non-equilibrium cellular conditions 





Anemia, 5q- syndrome and ICA are all ribosomopathies that may exhibit 
ribosomal distributions that are synonymous with tissue development defects. 
 
Figure 32: The ribosome quasispecies model and implications. 
All cells at equilibrium contain a habitable zone, a range in which ribosomes must translate in 
order to maintain cellular homeostasis. The variety of ribosomes and their inherent 
idiosyncratic translating properties generate a buffering zone that ensures optimal cellular 
functions. In scenarios where an even distribution of ribosomes is thermodynamically costly, 
only the essential ribosomal variants are produced and are able to maintain homeostasis. 
Ribosomopathies, a diseased state, forces these ribosomes variants exist and translate 
outside the habitable zone and their subtle translational defects accumulate to present the 
corresponding phenotype. 
 
There are two challenges that need to be overcome for further studies. 
First, how to biochemically isolate a “specialized” ribosome and test its activity 
and second, how to resolve individual ribosomes from homogenous 
ribosomes. The means to study of an individual ribosome are currently 
unknown, however, probing for ribosomal variation within a population is 





stem cells and patient cells to distinguish post-transcriptional modification 
patterns at each stage of tissue development for “hits” at sites known to be 
modified is a potential method to identify heterogeneity of ribosomes. While it 
does not identify or isolate individual ribosomes, ribosomes may exhibit 
differential post-transcriptional modification patterns (via pseudo-
uridylation/methylation) at different stages of cellular/tissue differentiation. 
This may provide a means to recognize the influences in translational 
patterns that heterogeneously composed ribosomes have in cellular 
functions/differentiation. 
This paradigm shift in understanding ribosomes offers a fresh insight 












Chapter 4: Materials and Methods 
Experimental Procedures 
Dual Luciferase Assays 
Dual luciferase assays were performed using a Turner Biosystems 
GloMax-Multi Microplate Multimode Reader and Dual Luciferase Reagent Kit 
from Promega. Data analysis were performed as described in (240). 
The dual luciferase reporter plasmids pYDL-control, pYDL-LA, pYDL-
CDC13, pYDL-EST1, pYDL-EST2, pYDL-STN1, pYDL-OAZ1, pYDL-Ty1, 
pYDL-GCN4, pYDL-UAA , pYDL-UAG, pYDL-UGA, and pYDL-AGC218 and 
pYDL-TCT218 were employed to quantitatively monitor programmed -1 
ribosomal frameshifting, programmed +1 ribosomal frameshifting, 
suppression of UAA, UGA, UAG codons, and suppression of an AGC near-
cognate serine codon and a TCT non-cognate serine codon in place of the 
cognate AGA codon in the firefly luciferase catalytic site, respectively (241, 
242).  
The reporters were expressed from high-copy URA3-based plasmids 
(pJD375, pJD376, pJD1803, pJD1019, pJD1039, pJD1041, pJD1943, 
pJD377, pJD1982, pJD1983, pJD431, pJD432, pJD433, pJD642, pJD643 
respectively) Assays were performed as previously described (240). 
Yeast cells were grown to mid-log phase before analysis. The cells 
were lysed using glass beads in a PBS buffered lysis solution containing a 





dilutions were depending on the cell culture volume. The lysates were then 
aliquoted in an initial volume of 50 µl (as compared to suggested 100 µl) into 
each well of the 96 well plates and each Renilla and Firefly luciferase 
substrates were measured in the luminometer.  All assays were repeated at 
least 4 times. 
 
Quantitative Real Time Reverse Transcriptase Polymerase  
Chain Reaction (qRT-PCR) 
Yeast cells were grown to mid-log phase and RNA samples were 
isolated using Trizol Reagent protocol DNAse digestion was performed using 
the RNA Microaqueous kit from Ambion (Life Technologies). The RNA 
samples were then assayed for contamination using RNAse-free agarose gel 
electrophoresis and OD260/280 measurements. The pure RNA samples were 
reverse transcribed to generate cDNA by using the iScript cDNA synthesis kit 
from Bio-Rad. cDNA was diluted 1:100 – 1:10,000 depending the RNA 
concentration. Reactions were performed using the iTaq Universal SYBR 
green mix from Bio-Rad. Reactions were amplified using the Bio-Rad CFX 96 
thermocycler as follows: 25˚C for 10 seconds, 95˚C for 5 min, followed by 45-
60 cycles of 95˚C for 10 seconds, 48˚C for 15 seconds, and 72˚C for 15 
seconds.  Melting curves were monitored by taking readings every 0.5˚C from 








Transformations using the bacterial strain DH5α were performed as described 
in (243). 
Yeast Transformations 
Yeast strains were transformed using modified alkali cation method as 
described in (244). Yeast cells were grown in mid-log phase in YPAD or the 
appropriate selective media. Transformations were performed using 0.1 M 
LiOAc/TE and excess (400 µl) PEG/LiOAc/TE buffers. Approximately double 
amount of ssDNA was used.  The sample were incubated at 30°C for 30-90 
minutes (approximately double time recommended incubation time). The cells 
were heat shocked at 42°C for 15 minutes before spinning the samples down, 
removing the supernatant and resuspending the pellet in approximately 60-
100 µl nuclease-free water solution. The resulting solution were then spread 
onto petri dishes containing the appropriate selective media. 
Statistical Analysis 
Student’s t test for two-tailed p-value calculations was used 
throughout. Data analysis of dual-luciferase assays was carried out as 
























yJD1573 MAT α his3-1; leu2-0; lys2-0; ura3-0; YGR214W::KanR rpS0A deletion 
yJD1574 MAT α his3-1; leu2-0; lys2-0; ura3-0; YLR048W::KanR rpS0B deletion 
yJD1575 MAT α his3-1; leu2-0; lys2-0; ura3-0; YCR031C::KanR rpS14A deletion 
 
yJD1577 MAT α his3-1; leu2-0; lys2-0; ura3-0; YOL121C::KanR rpS19A deletion 
yJD1578 MAT α his3-1; leu2-0; lys2-0; ura3-0; YNL302C::KanR 
 
rpS19B deletion 






Obtaining Knock Out Yeast Strains 
Gene knockout yeast strains were purchased from Invitrogen’s 
Saccharomyces Genome Deletion Project. Targeted gene knockouts were 






















pJD0375 pRS316 Dual luciferase cassette in pRS316, genomic context 
pJD0376 pJD375 LA frameshift signal sequence inserted in dual luciferase 
reporter, viral context 
pJD0377 pJD375 Tyl frameshift signal sequence inserted in dual luciferase 
reporter, viral context 
pJD0431 pJD375 In-frame UAA stop codon sequence inserted downstream 
of Renilla in dual luciferase reporter 
pJD0432 pJD375 In-frame UAG stop codon sequence inserted downstream 
of Renilla in dual luciferase reporter 
pJD0433 pJD375 In-frame UGA stop codon sequence inserted downstream 
of Renilla in dual luciferase reporter 
pJD0521 pJD375 EST2 PRF sequence at 1653 inserted in dual luciferase 
reporter, viral context 
pJD0642 pJD375 In-frame non-cognate TCT R218S mutation in firefly 
sequence of dual luciferase reporter 
pJD0643 pJD375 In-frame near-cognate AGC R218S mutation in firefly 
sequence of dual luciferase reporter 
pJD0753 pJD0741 Readthrough containing small amounts of Renilla and 
Firefly in PGK1 reporter 
pJD0828 pJD753 Premature termination codon in PGK1 reporter 
pJD1018 pJD375 EST2 PRF sequence at 1215 inserted in dual luciferase 
reporter, viral context 
pJD1019 pJD375 EST2 PRF sequence at 1326 inserted in dual luciferase 
reporter, viral context 
pJD1038 pJD375 STN1 PRF sequence at 885 inserted in dual luciferase 
reporter, viral context 
pJD1039 pJD375 STN1 PRF sequence at 1203 inserted in dual luciferase 
reporter, viral context 
pJD1041 pJD375 EST1 PRF sequence at 1272 inserted in dual luciferase 
reporter, viral context 
pJD1803 pJD375 CDC13 PRF sequence at 1272 inserted in dual luciferase 
reporter, viral context 
pJD1943 pJD375 OAZ1 PRF signal inserted in dual luciferase reporter, viral 
context 
pJD1982 pJD375  In-frame GCN4 readthrough control sequence in dual 
luciferase reporter 
















Name Template Sequence 
yEST2 Fwd Yeast cDNA 5’-TGG TCG GTA CAT ACG CAT TC-3’ 
yEST2 Rev Yeast cDNA 5’-CGG CAG ATG AGG TTC GTT AC-3’ 
yEST1 Fwd Yeast cDNA 5’-ATT CCG TGA TAC CAT TGG TTC-3’ 
yEST1 Rev Yeast cDNA 5’-CTT TCT TCT GTT ACT TAG TCG CA-3’ 
ySTN1 Fwd Yeast cDNA 5’-ACA GCA AAT ACA CCT TAT TGG C-3’ 
ySTN1 Rev Yeast cDNA 5’-ACC AAT GAA GAG TCT GAA GTA CA-3’ 
yCDC13 Fwd Yeast cDNA 5’-TGG TAA GTG TGA TAA GCA CC-3’ 
yCDC13 Rev Yeast cDNA 5’-AGA TAT CCA CAA GTG AGT TGT-3’ 
yPGK1-DLR Rev Exogenous PGK1 5’-GTT CGT TGA GCG AGT TCT CA-3’ 
yPGK1-DLR Fwd Exogenous PGK1 5’-GGT ACC GGC GTC TTC CAT-3’ 
U3 Forward Yeast cDNA 5’-TCC AAC TTG GTT GAT GAG TCC-3’ 
U3 Reverse Yeast cDNA 5’-CGA ACC GCT AAG GAT TGC-3’ 
yCCR4 Fwd Yeast cDNA 5’-AGC AAT CTC ACA TTG CAG AAG C-3’ 
yCCR4 Rev Yeast cDNA 5’-CGT AGG TTG TTG TTT CTT TGC T-3’ 
yGCN4 Fwd Yeast cDNA 5’-ACA TTC CAG TTA CCA CTG ACG ATG T-3’ 
yGCN4 Rev Yeast cDNA 5’-GGG TAA GAA TGA AGT TGT CGA GAC TTC-3’ 
yTel Fwd Yeast gDNA 5’-CAGTGGTGTGGG TGT GCATGGTGGTGTGGGTGTGTGG-3’ 
yTel Rev Yeast gDNA 5’-GCCCACAACCACACCCAACACATCCCACACCACCCAC-3’ 
yHOM3 Fwd Yeast cDNA 5’-CTA AAC CTG ACG GCC CAA AC-3’ 
yHOM3 Rev Yeast cDNA 5’-GAA ATT CAG ATT CTT GCG AAG C-3’ 
yADE4 Fwd Yeast cDNA 5’-ATT AGC AAA CCA AAC CAC TCC AG-3’ 
yADE4 Rev Yeast cDNA 5’-CGT CAC GAG CCA TAC CAT TAC-3’ 
yLUC7 Fwd Yeast cDNA 5’-ACG CAA ACT CGT CGA ACA G-3’ 
yLUC7 Rev Yeast cDNA 5’-GCA CTC GCC AAC AAG GTA TG-3’ 
yBRR6 Fwd Yeast cDNA 5’-CTA GAC AGC CTG ATG GCA TAC-3’ 
yBRR6 Rev Yeast cDNA 5’-GCA ATT AAA CTT GGG CTC AAC C-3’ 
yPRP8 Fwd Yeast cDNA 5’-TTG AAG AGG ACA GCG ACT TAG-3’ 
yPRP8 Rev Yeast cDNA 5’-GTG GAG GCG GAA GGA ATG TAT C-3’ 
yACT1 Fwd Yeast cDNA 5’-GGT TGC TGC TTT GGT TAT TG-3’ 
yACT1 Rev Yeast cDNA 5’-TTT GAC CCA TAC CGA CCA TGA TAC-3’ 
yTUB1 Fwd Yeast cDNA 5’-GCT GGT TGT CAG ATT GGT AAT G-3’ 
yTUB1 Rev Yeast cDNA 5’-GAA ACC CTC TTC TCC TCC CTT CG-3’ 
yRPS0 Fwd Yeast cDNA 5’-GTT GTT GCC ATC TCT TCC AG-3’ 
yRPS0 Rev Yeast cDNA 5’-GTG AAA GAA CCT GGA GTG AAT C-3’ 
yRPS14 Fwd Yeast cDNA 5’-TGT TAC CGA TTT ATC TGG TAA GG-3’ 
yRPS14 Rev Yeast cDNA 5’-TTA CAC TTA GCG GCA ACA TC-3’ 
yRPS19 Fwd Yeast cDNA 5’-TGC TTA CGC TTC TTT CTT GC-3’ 





Chapter 5:  Supplementary Data 
 
Supplementary Table 1: Dual Luciferase Reporter Assay – Translational 
Recoding Rates 
The following table presents Translational Fidelity efficiencies as calculated 






 𝒙 𝟏𝟎𝟎 
This table contains dual luciferase translational efficiencies from 5 reporters 
that measure -1 PRF rates, 4 reporters that measure stop codon read through 
rates, 2 reporters that measure missense incorporation rates and 1 reporters 
that measure +1 PRF rates. 
  WT  S0A∆ S0B∆ S14A∆ S14B∆ S19A∆ S19B∆ 
-1 PRF               
LA 6.98% + 
0.29% 
9.53% +  
0.94% 
7.32% +  
0.67% 
7.11% +  
0.58% 
9.34% +  
0.88% 
7.61% +  
0.71% 
10.98% +  
0.87% 
CDC13 1.80% + 
0.09% 
3.09% +  
0.38% 
1.09% +  
0.10% 
0.84% +  
0.05% 
2.09% +  
0.78% 
1.62% +  
0.13% 
1.83% +  
0.08% 
EST1  0.22% +  
0.01% 
0.27% +  
0.02% 
0.25% +  
0.01% 
0.81% +  
0.10% 
0.49% +  
0.09% 
0.17% +  
0.01% 
0.36% +  
0.03% 
EST2  1.62% +  
0.06% 
1.58% +  
0.08% 
1.53% +  
0.13% 
0.95% +  
0.08% 
1.78% +  
0.06% 
1.38% +  
0.08% 
1.81% +  
0.17% 
STN1  2.58% +  
0.14% 
2.68% +  
0.26% 
4.71% +  
0.48% 
2.63% +  
0.14% 
1.61% +  
0.23% 
3.89% +  
0.42% 
7.88% +  
0.43% 
Stop Codon Readthrough       




2.53% +  
0.63% 
4.75% +  
1.22% 
7.85% +  
1.92% 
7.28% +  
1.08% 
3.15% +  
0.39% 
UAA 0.21% +  
0.01% 
0.32% +  
0.04% 
0.41% +  
0.04% 
0.32% +  
0.02% 
0.30% +  
0.03% 
0.58% +  
0.05% 
0.84% +  
0.06% 
UAG 0.22% +  
0.01% 
0.57% +  
0.06% 
0.33% +  
0.03% 
0.32% +  
0.02% 
0.29% +  
0.03% 
0.47% +  
0.04% 
0.53% +  
0.03% 
UGA 0.46% +  
0.02% 
1.38% +  
0.12% 
0.83% +  
0.06% 
0.76% +  
0.09% 
0.60% +  
0.07% 
0.64% +  
0.14% 
2.47% +  
0.23% 
Missense Incorporation       
Non C 0.06% +  
0.004% 




0.04% +  
0.001% 
0.05% +  
0.001% 
0.11% +  
0.004% 
0.06% +  
0.002% 
Near C 0.14% +  
0.012% 
0.18% +  
0.004% 
0.13% +  
0.006% 
0.13% +  
0.004% 
0.14% +  
0.003% 
0.15% +  
0.006% 
0.26% +  
0.005% 
+1 PRF         
OAZ1 0.23% +  
0.01% 
0.51% +  
0.02% 
0.39% +  
0.03% 
0.21% +  
0.01% 
0.21% +  
0.03% 
0.23% +  
0.01% 
0.26% +  
0.02% 


















Supplementary Table 2: Dual Luciferase Reporter Assay, Fold Wild-type 
Translational Recoding Rates 
This table presents the values obtained by comparing the translational 
recoding rates of the mutant yeast strains to that of the wild-type control 
strain. Fold wild-type is calculated by the following formula: 
% 𝒕𝒓𝒂𝒏𝒔𝒍𝒂𝒕𝒊𝒐𝒏𝒂𝒍 𝒓𝒆𝒄𝒐𝒅𝒊𝒏𝒈 𝒓𝒂𝒕𝒆𝒎𝒖𝒕𝒂𝒏𝒕
% 𝒕𝒓𝒂𝒏𝒔𝒍𝒂𝒕𝒊𝒐𝒏𝒂𝒍 𝒓𝒆𝒄𝒐𝒅𝒊𝒏𝒈 𝒓𝒂𝒕𝒆𝒘𝒊𝒍𝒅−𝒕𝒚𝒑𝒆
 
 
  WT  S0A∆ S0B∆ S14A∆ S14B∆ S19A∆ S19B∆ 
-1 PRF               
LA 1.00 1.37 1.05 1.02 1.34 1.09 1.57 
CDC13 1.00 1.71 0.60 0.46 1.16 0.90 1.02 
EST1  1.00 1.20 1.10 3.65 2.21 0.77 1.61 
EST2  1.00 0.97 0.94 0.58 1.09 0.85 1.12 
STN1  1.00 1.04 1.83 1.02 0.62 1.51 3.06 
Stop Codon Readthrough         
GCN4  1.00 3.89 1.92 3.60 5.94 5.52 2.39 
UAA 1.00 1.55 1.99 1.53 1.47 2.82 4.06 
UAG 1.00 2.58 1.49 1.46 1.32 2.14 2.37 
UGA 1.00 3.03 1.82 1.66 1.32 1.41 5.41 
Missense Incorporation           
Non C 1.00 1.41 0.96 0.64 0.87 1.87 1.04 
Near C 1.00 1.29 0.95 0.94 1.02 1.05 1.83 
+1 PRF               
OAZ1 1.00 2.20 1.68 0.88 0.91 0.99 1.11 











Supplementary Table 3: Number of biological samples used per Dual 
Luciferase assay 
The table below contains the total number of biological samples used to obtain statistical 
values. 
  WT  S0A∆ S0B∆ S14A∆ S14B∆ S19A∆ S19B∆ 
Control       
RT 53 22 20 17 14 29 19 
-1 PRF               
LA 18 4 3 4 3 5 4 
CDC13 18 6 4 3 3 4 3 
EST1  16 4 3 5 3 4 5 
EST2  21 3 3 5 3 6 6 
STN1  20 4 4 3 4 5 4 
Stop Codon Readthrough         
RT GCN4  14 4 5 4 4 10 10 
GCN4  7 7 8 7 7 11 4 
UAA 22 4 5 4 4 8 9 
UAG 23 3 3 3 5 7 6 
UGA 26 4 4 4 4 10 9 
Missense Incorporation           
Non C 10 3 5 3 4 4 4 
Near C 7 3 3 3 3 3 3 
+1 PRF               
OAZ1 19 3 3 3 4 6 4 











Supplementary Table 4: Dual Luciferase Reporter Assay – Translational Recoding calculated p-values 
p-values in this table were calculated as described (240). Each reporter of the dual luciferase assays measuring translational recoding rates is 
presented in two forms; the numerical p-value and the asterisk system denoting its corresponding p-value. The relationship between the numerical 
value and the asterisks are shown in the legend below 
  
P > 0.05 P ≤ 0.05 P ≤ 0.01 P ≤ 0.001  P ≤ 0.0001  
Not significant (ns) * ** *** **** 













































S0A∆ ** *** ns ns ns *** ** *** *** ns ns *** ** 
S0B∆ ns *** ns ns *** ns *** ns *** ns ns ** ns 









































S14A∆ ns *** *** *** ns *** *** ** ** *** ns ns ns 
S14B∆ ns ns ** ns *** *** ** ** ns ns ns ns ns 









































S19A∆ ns ns ns ns ** *** *** *** ns ** ns ns ns 





Supplementary Table 5: quantitative Real Time PCR – Steady state 
mRNA abundance Fold Wild-type  
Steady state mRNA abundances were measured by qualitative Real 
Time PCR. The mRNA abundances of each probe was normalized to U3, a 
stable non-coding RNA message. The abundance of the probe in a mutant 
yeast strain is the compared to the abundance of the same message in the 
wild-type control yeast strain. The calculations can be visualized by the 
following formula: 
(
𝑎𝑏𝑢𝑛𝑑𝑎𝑛𝑐𝑒 𝑜𝑓 𝑡𝑎𝑟𝑔𝑒𝑡 𝑚𝑒𝑠𝑠𝑎𝑔𝑒
𝑎𝑏𝑢𝑛𝑑𝑎𝑛𝑐𝑒 𝑜𝑓 𝑈3 𝑚𝑒𝑠𝑠𝑎𝑔𝑒
)𝑚𝑢𝑡𝑎𝑛𝑡
(
𝑎𝑏𝑢𝑛𝑑𝑎𝑛𝑐𝑒 𝑜𝑓 𝑡𝑎𝑟𝑔𝑒𝑡 𝑚𝑒𝑠𝑠𝑎𝑔𝑒
𝑎𝑏𝑢𝑛𝑑𝑎𝑛𝑐𝑒 𝑜𝑓 𝑈3 𝑚𝑒𝑠𝑠𝑎𝑔𝑒
)𝑤𝑖𝑙𝑑−𝑡𝑦𝑝𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 
The table below contains steady state mRNA abundances fold wild-
type for messages that contain a -1 PRF signal, a message that contains 
multiple uORFs (GCN4), messages that contains a +1 PRF signal, messages 
that are substrates for mRNA decay, messages that encode for housekeeping 
proteins, messages that encode for ribosomal proteins and, messages that 














 WT S0A∆ S0B∆ S14A∆ S14B∆ S19A∆ S19B∆ 
-1 PRF        
CDC13 
1.00 
2.45 +  
0.42 
2.31 +  
0.30 
3.82 +  
0.78 
5.57 +  
0.57 
0.40 +  
0.16 




0.46 +  
0.04 
0.43 +  
0.08 
0.77 +  
0.21 
1.16 +  
0.21 
0.62 +  
0.22 




0.48 +  
0.08 
0.47 +  
0.09 
0.80 +  
0.11 
0.98 +  
0.28 
0.51 +  
0.15 




0.36 +  
0.06 
0.39 +  
0.07 
0.58 +  
0.10 
0.72 +  
0.25 
0.48 +  
0.17 
0.20 +  
0.07 
+1 PRF           
EST3 
1.00 
0.22 +  
0.04 
0.19 +  
0.01 
0.35 +  
0.05 
0.43 +  
0.19 
0.74 +  
0.08 




0.48 +  
0.05 
0.54 +  
0.08 
0.69 +  
0.20 
0.99 +  
0.31 
0.41 +  
0.15 
0.13 +  
0.04 
Substrates for NMD       
GCN4 
1.00 
0.24 +  
0.06 
0.23 +  
0.07 
0.32 +  
0.07 
0.38 +  
0.11 
0.60 +  
0.21 




0.31 +  
0.08 
0.43 +  
0.001 
0.48 +  
0.03 
0.87 +  
0.22 
0.58 +  
0.004 




0.30 +  
0.10 
0.35 +  
0.08 
0.46 +  
0.05 
0.57 +  
0.19 
0.49 +  
0.10 
0.19 +  
0.02 

















0.51 +  
0.05 
0.50 +  
0.07 
0.60 +  
0.12 
0.66 +  
0.10 
0.58 +  
0.02 




0.43 +  
0.11 
0.67 +  
0.29 
0.68 +  
0.12 
1.44 +  
0.21 
0.53 +  
0.03 




0.22 +  
0.03 
0.17 +  
0.06 
0.50 +  
0.02 
0.84 +  
0.04 
0.37 +  
0.16 
















Ribosomal Proteins         
S0 
1.00 
0.20 +  
0.02 
0.15 +  
0.02 
0.46 +  
0.07 
0.52 +  
0.16 
0.82 +  
0.07 




0.26 +  
0.05 
0.22 +  
0.01 
0.22 +  
0.04 




















Cellular Stress/Ribosomal Turnover    
ADE4 
1.00 
3.81 +  
0.86 
2.38 +  
0.29 
7.79 +  
2.06 








4.84 +  
1.17 
4.19 +  
0.70 
5.47 +  
0.78 
6.49 +  
1.02 
0.50 +  
0.03 




1.11 +  
0.18 
1.45 +  
0.24 
1.81 +  
0.43 
1.86 +  
0.65 






0.92 +  
0.18 
0.83 +  
0.04 
















8.02 +  
2.35 








Supplementary Table 6: Number of biological samples used per 
quantitative Real Time PCR assay 







Student’s t-test S0A∆ S0B∆ S14A∆ S14B∆ S19A∆ S19B∆ 
-1 PRF       
CDC13 3 3 3 3 4 3 
EST1 3 3 3 3 4 3 
EST2 5 4 4 3 5 4 
STN1 3 3 5 3 4 3 
+1 PRF       
EST3 3 3 3 3 4 3 
OAZ1 3 4 5 3 3 3 
Substrates for NMD      
GCN4 3 3 3 3 5 3 
CPA1 3 3 3 3 3 3 
NMD4 3 3 3 3 4 3 
Housekeeping genes       
ACT1 4 5 5 3 3 3 
BRR6 3 3 3 3 3 3 
HOM3 4 3 3 3 3 3 
PGK1 3 3 3 3 3 3 
TUB1 4 4 4 3 5 3 
Ribosomal Proteins       
S0 3 3 3 3 5 4 
S14 3 3 3 3 4 4 
S19 3 3 3 3 5 4 
Cellular Stress Ribosomal Turnover 
ADE4 4 4 4 3 3 3 
CCR4 3 3 3 2 3 3 
HAC1 3 3 3 3 3 3 
LUC7 4 3 3 3 3 3 





Supplementary Table 7: quantitative Real Time PCR – Steady state 
mRNA abundance Student’s t-test calculations 





Student’s t-test S0A∆ S0B∆ S14A∆ S14B∆ S19A∆ S19B∆ 
-1 PRF       
CDC13 1.34E-02 8.53E-03 1.23E-02 2.53E-03 1.16E-02 9.44E-04 
EST1 9.25E-04 3.01E-03 7.58E-04 1.56E-01 4.63E-02 9.21E-04 
EST2 3.77E-03 4.47E-03 4.26E-02 4.47E-01 1.49E-02 9.23E-04 
STN1 1.55E-03 2.39E-03 1.01E-02 3.08E-03 1.62E-02 1.38E-03 
+1 PRF       
EST3 4.67E-04 3.02E-05 9.22E-04 1.75E-02 5.42E-02 7.23E-04 
OAZ1 1.42E-03 5.15E-03 5.90E-02 1.46E-02 1.02E-02 4.27E-04 
Substrates for NMD      
GCN4 9.09E-04 1.49E-03 1.86E-03 5.44E-03 4.10E-02 1.55E-03 
CPA1 2.34E-03 1.04E-06 6.44E-04 2.14E-01 1.68E-05 1.09E-04 
NMD4 3.24E-03 2.46E-03 1.40E-03 2.93E-02 8.48E-03 6.61E-05 
Housekeeping genes       
ACT1 6.22E-04 5.77E-05 3.64E-01 9.01E-02 9.91E-05 7.81E-05 
BRR6 6.47E-04 3.64E-03 3.14E-03 2.22E-03 2.88E-04 1.87E-03 
HOM3 9.03E-04 9.50E-02 6.02E-03 3.39E-02 5.82E-04 9.72E-04 
PGK1 3.07E-04 9.26E-04 2.65E-04 1.48E-03 1.05E-02 1.10E-03 
TUB1 2.13E-02 3.64E-01 2.68E-03 5.43E-02 2.15E-04 4.37E-05 
Ribosomal Proteins       
S0 9.24E-05 8.61E-05 2.48E-03 1.70E-02 2.34E-02 1.01E-04 
S14 8.91E-04 9.39E-06 4.64E-04 3.71E-03 4.98E-03 3.45E-05 
S19 2.11E-04 2.83E-04 1.42E-03 3.67E-03 7.93E-04 1.29E-08 
Cellular Stress Ribosomal Turnover 
ADE4 3.69E-03 1.27E-03 3.56E-03 9.00E-04 1.96E-02 9.52E-05 
CCR4 1.49E-02 7.79E-03 5.06E-03 5.64E-03 4.29E-04 6.19E-05 
HAC1 2.01E-01 4.25E-02 3.17E-02 7.42E-02 1.13E-03 9.47E-04 
LUC7 3.33E-01 1.08E-02 3.65E-02 2.20E-02 2.10E-03 4.65E-04 
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